| Ident. | Authors (with country if any) | Title |
|---|
| 000001 |
Leigh Christopher [Canada] ; Yuko Koshimori [Canada] ; Anthony E. Lang [Canada] ; Marion Criaud [Canada] ; Antonio P. Strafella [Canada] | Uncovering the role of the insula in non-motor symptoms of Parkinson's disease |
| 000002 |
Magda Osman [Royaume-Uni] ; Agata Rytersk [Royaume-Uni] ; Kash Karimi [Royaume-Uni] ; LINGLING TU [République populaire de Chine] ; Ignacio Obeso [Canada] ; Maarten Speekenbrink [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] | The effects of dopaminergic medication on dynamic decision making in Parkinson's disease |
| 000003 |
Stéphanie Bissonnette [Canada] ; Sophie Muratot [Canada] ; Nathalie Vernoux [Canada] ; François Bezeau [Canada] ; Frédéric Calon [Canada] ; Sébastien S. Hebert [Canada] ; Pershia Samadi [Canada] | The effect of striatal pre-enkephalin overexpression in the basal ganglia of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease |
| 000004 |
Marc D. Pell [Canada] ; Laura Monetta [Canada] ; Kathrin Rothermich [Canada] ; Sonja A. Kotz [Royaume-Uni, Allemagne] ; Henry S. Cheang [Canada] ; Skye Mcdonald [Australie] | Social Perception in Adults With Parkinson's Disease |
| 000005 |
Michel Panisset [Canada] ; Jack J. Chen [États-Unis] ; Sean H. Rhyee [États-Unis] ; Jill Conner [États-Unis] ; Julie Mathena [États-Unis] | Serotonin Toxicity Association with Concomitant Antidepressants and Rasagiline Treatment: Retrospective Study (STACCATO) |
| 000006 |
Santiago Perez-Lloret [France] ; María Ver Nica Rey [France] ; James Crispo [Canada] ; Daniel Krewski [Canada] ; Marise Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France] | Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients |
| 000007 |
Barbara S. Connolly [Canada] ; Anthony E. Lang [Canada] | Pharmacological Treatment of Parkinson Disease A Review |
| 000008 |
Kay Teschke [Canada] ; Stephen A. Marion [Canada] ; Joseph K. C. Tsui [Canada] ; HUI SHEN [Canada] ; Kathrine Rugbjerg [Canada, Danemark] ; M. Anne Harris [Canada] | Parkinson's Disease and Occupation: Differences in Associations by Case Identification Method Suggest Referral Bias |
| 000011 |
C. H. Carriere [Canada] ; N. H. Kang [Canada] ; L. P. Niles [Canada] | NEUROPROTECTION BY VALPROIC ACID IN AN INTRASTRIATAL ROTENONE MODEL OF PARKINSON'S DISEASE |
| 000012 |
A. Jon Stoessl [Canada] ; Stephane Lehericy [France] ; Antonio P. Strafella [Canada] | Movement disorders 2:Imaging insights into basal ganglia function, Parkinson's disease, and dystonia |
| 000013 |
Frederico Pieruccini-Faria [Canada] ; Jeffery A. Jones [Canada] ; Quincy J. Almeida [Canada] | Motor planning in Parkinson's disease patients experiencing freezing of gait: The influence of cognitive load when approaching obstacles |
| 000014 |
Nicolas Morin [Canada] ; Vincent A. Jourdain ; Thérèse Di Paolo | Modeling dyskinesia in animal models of Parkinson disease : ANIMAL MODELS OF PARKINSON'S DISEASE |
| 000015 |
Alexandru Hanganu [Canada] ; Christophe Bedetti [Canada] ; Clotilde Degroot [Canada] ; Beatriz Mejia-Constain [Canada] ; Anne-Louise Lafontaine [Canada] ; Valerie Soland [Canada] ; Sylvain Chouinard [Canada] ; Marie-Andrée Bruneau [Canada] ; Samira Mellah [Canada] ; Sylvie Belleville [Canada] ; Oury Monchi [Canada] | Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally |
| 000017 |
Damian M. Herz [Allemagne, Danemark] ; Hartwig R. Siebner [Danemark] ; Oliver J. Hulme [Danemark] ; Esther Florin [Allemagne, Canada] ; Mark S. Christensen [Danemark] ; Lars Timmermann [Allemagne] | Levodopa reinstates connectivity from prefrontal to premotor cortex during externally paced movement in Parkinson's disease |
| 000018 |
YIMING XIAO [Canada] ; Pierre Jannin [France] ; Tiziano D'Albis [France] ; Nicolas Guizard [Canada] ; Claire Haegelen [France] ; Florent Lalys [France] ; Marc Verin [France] ; D. Louis Collins [Canada] | Investigation of Morphometric Variability of Subthalamic Nucleus, Red Nucleus, and Substantia Nigra in Advanced Parkinson's Disease Patients Using Automatic Segmentation and PCA-Based Analysis |
| 000019 |
Jessie Theuns [Belgique] ; Aline Verstraeten [Belgique] ; Kristel Sleegers [Belgique] ; Eline Wauters [Belgique] ; Ilse Gijselinck [Belgique] ; Stefanie Smolders [Belgique] ; David Crosiers [Belgique] ; Ellen Corsmit [Belgique] ; Ellen Elinck [Belgique] ; Manu Sharma [Allemagne] ; Rejko Krüger [Allemagne] ; Suzanne Lesage [France] ; Alexis Brice [France] ; SUN JU CHUNG [Corée du Sud] ; Mi-Jung Kim [Corée du Sud] ; YOUNG JIN KIM [Corée du Sud] ; Owen A. Ross [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; Ekaterina Rogaeva [Canada] ; ZHENGRUI XI [Canada] ; Anthony E. Lang [Canada] ; Christine Klein [Allemagne] ; Anne Weissbach [Allemagne] ; George D. Mellick ; Peter A. Silburn [Australie] ; Georgios M. Hadjigeorgiou [Australie] ; Efthimios Dardiotis [Grèce] ; Nobutaka Hattori [Japon] ; Kotaro Ogaki [Japon] ; Eng-King Tan [Singapour] ; YI ZHAO [Singapour] ; Jan Aasly [Norvège] ; Enza Maria Valente [Italie] ; Simona Petrucci [Italie] ; Grazia Annesi ; Aldo Quattrone ; Carlo Ferrarese ; Laura Brighina ; Angela Deutschl Nder ; Andreas Puschmann ; Christer Nilsson ; Gaëtan Garraux ; Mark S. Le Doux ; Ronald F. Pfeiffer ; Magdalena Boczarska-Jedynak ; Grzegorz Opala ; Demetrius M. Maraganore ; Sebastian Engelborghs [Belgique] ; Peter Paul De Deyn [Belgique, Pays-Bas] ; Patrick Cras ; Marc Cruts [Belgique] ; Christine Van Broeckhoven [Belgique] | Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease |
| 000020 |
Cristina Nombela [Royaume-Uni] ; James B. Rowe [Royaume-Uni] ; Sophie E. Winder-Rhodes [Royaume-Uni] ; Adam Hampshire [Royaume-Uni] ; Adrian M. Owen [Canada] ; David P. Breen [Royaume-Uni] ; Gordon W. Duncan [Royaume-Uni] ; Tien K. Khoo [Australie] ; Alison J. Yarnall [Royaume-Uni] ; Michael J. Firbank [Royaume-Uni] ; Patrick F. Chinnery [Royaume-Uni] ; Trevor W. Robbins [Royaume-Uni] ; John T. O'Brien [Royaume-Uni] ; David J. Brooks [Royaume-Uni, Danemark] ; David J. Burn [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] | Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study |
| 000021 |
Alexandra Nadeau [Canada] ; Emmanuelle Pourcher [Canada] ; Philippe Corbeil [Canada] | Effects of 24 wk of Treadmill Training on Gait Performance in Parkinson's Disease |
| 000023 |
Francesca Antonelli [Canada] ; JI HYUN KO [Canada] ; Janis Miyasaki [Canada] ; Anthony E. Lang [Canada] ; Sylvain Houle [Canada] ; Franco Valzania [Italie] ; Nicola J. Ray [Canada] ; Antonio P. Strafella [Canada] | Dopamine-Agonists and Impulsivity in Parkinson's Disease: Impulsive Choices vs. Impulsive Actions |
| 000024 |
Claudine Habak [Canada] ; Anne Noreau [Canada] ; Atsuko Nagano-Saito [Canada] ; Beatriz Mejia-Constain [Canada] ; Clotilde Degroot [Canada] ; Antonio P. Strafella [Canada] ; Sylvain Chouinard [Canada] ; Anne-Louise Lafontaine [Canada] ; Guy A. Rouleau [Canada] ; Oury Monchi [Canada] | Dopamine transporter SLC6A3 genotype affects cortico-striatal activity of set-shifts in Parkinson's disease |
| 000025 |
Claudio Pollo [Suisse] ; Alain Kaelin-Lang [Suisse] ; Markus F. Oertel [Suisse] ; Lennart Stieglitz [Suisse] ; Ethan Taub [Suisse] ; Peter Fuhr [Suisse] ; Andres M. Lozano [Canada] ; Andreas Raabe [Suisse] ; Michael Schüpbach [Suisse] | Directional deep brain stimulation: an intraoperative double-blind pilot study |
| 000028 |
D. Ouazia [Canada] ; L.-C. Jr Levros [Canada] ; E. Rassart [Canada] ; R. R. Desrosiers [Canada] | DOPAMINE DOWN-REGULATION OF PROTEIN L-ISOASPARTYL METHYLTRANSFERASE IS DEPENDENT ON REACTIVE OXYGEN SPECIES IN SH-SY5Y CELLS |
| 000029 |
Leigh Christopher [Canada] ; Connie Marras [Canada] ; Sarah Duff-Canning [Canada] ; Yuko Koshimori [Canada] ; Robert Chen [Canada] ; Isabelle Boileau [Canada] ; Barbara Segura [Canada, Espagne] ; Oury Monchi [Canada] ; Anthony E. Lang [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Antonio P. Strafella [Canada] | Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment |
| 000032 |
Tiago A. Mestre [Canada] ; Prakesh Shah [Canada] ; Connie Marras [Canada] ; George Tomlinson [Canada] ; Anthony E. Lang [Canada] | Another face of placebo: The lessebo effect in Parkinson disease: Meta-analyses |
| 000033 |
Mauro Pettorruso [Italie] ; Giovanni Martinotti [Italie] ; Alfonso Fasano [Canada] ; Giovanna Loria [Italie] ; Marco Di Nicola [Italie] ; Luisa De Risio [Italie] ; Lucia Ricciardi [Italie] ; Gianluigi Conte [Italie] ; Luigi Janiri [Italie] ; Anna Rita Bentivoglio [Italie] | Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study |
| 000034 |
Arthur G. Fitzmaurice [États-Unis] ; Shannon L. Rhodes [États-Unis] ; Myles Cockburn [États-Unis] ; Beate Ritz [États-Unis] ; Jeff M. Bronstein [États-Unis, Canada] | Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease |
| 000035 |
Anna Effenberg [Allemagne] ; Alexander Klein [Allemagne] ; Robbin Gibb [Canada] ; Cathy Carroll [Canada] ; Wolfgang Baumgartner [Allemagne] ; Claudia Grothea [Allemagne] ; Andreas Ratzka [Allemagne] | Adult hemiparkinsonian rats do not benefit from tactile stimulation |
| 000037 |
K. A. Ehgoetz Martens [Canada] ; C. G. Ellard [Canada] ; Q. J. Almeida [Canada] | A CLOSER LOOK AT MECHANISMS UNDERLYING PERCEPTUAL DIFFERENCES IN PARKINSON'S FREEZERS AND NON-FREEZERS |
| 000038 |
Julie Vachon-Joannette [Canada] ; Christina Tremblay [Canada] ; Mélanie Langlois [Canada] ; Sophie Chantal [Canada] ; Laura Monetta [Canada] | Les déficits de compréhension du langage non littéral dans la maladie de Parkinson sont-ils liés à un déficit de la théorie de l'esprit ? |
| 000039 |
Anthony N. Carlsen [Canada] ; Quincy J. Almeida [Canada] ; Ian M. Franks [Canada] | Using a startling acoustic stimulus to investigate underlying mechanisms of bradykinesia in Parkinson's disease |
| 000041 |
HONGLIU DING [Royaume-Uni] ; Kaltra Dhima [Royaume-Uni, États-Unis] ; Kaitlin C. Lockhart [Royaume-Uni, États-Unis] ; Joseph J. Locascio [États-Unis] ; Ashley N. Hoesing [Royaume-Uni, États-Unis] ; Karen Duong [Royaume-Uni, États-Unis] ; Ana Trisini-Lipsanopoulos [Royaume-Uni, États-Unis] ; Michael T. Hayes [États-Unis] ; U. Shivraj Sohur [États-Unis] ; Anne-Marie Wills [États-Unis] ; Brit Mollenhauer [États-Unis, Allemagne] ; Alice W. Flaherty [États-Unis] ; Albert Y. Hung [États-Unis] ; Nicte Mejia [États-Unis] ; Vikram Khurana [États-Unis] ; Stephen N. Gomperts [États-Unis] ; Dennis J. Selkoe [États-Unis] ; Michael A. Schwarzschild [États-Unis] ; Michael G. Schlossmacher [États-Unis, Canada] ; Bradley T. Hyman [États-Unis] ; Lewis R. Sudarsky [États-Unis] ; John H. Growdon [États-Unis] ; Clemens R. Scherzer [Royaume-Uni, États-Unis] | Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study |
| 000042 |
Philippe Huot [Canada] ; Susan H. Fox [Canada] | The serotonergic system in motor and non-motor manifestations of Parkinson's disease |
| 000044 |
James B. Koprich [Canada] ; Philippe Huot [Canada] ; Susan H. Fox [Canada] ; Keith Jarvie [Canada] ; Anthony E. Lang [Canada] ; Philip Seeman [Canada] ; Jonathan M. Brotchie [Canada] | The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques |
| 000045 |
Dimitri Ryczko [Canada] ; Réjean Dubuc [Canada] | The Multifunctional Mesencephalic Locomotor Region |
| 000047 |
Esther Florin [Allemagne, Canada] ; Désirée Müller [Allemagne] ; Johannes Pfeifer [Allemagne] ; Michael T. Barbe [Allemagne] ; Gereon R. Fink [Allemagne] ; Lars Timmermann [Allemagne] | Subthalamic stimulation modulates self-estimation of patients with Parkinson's disease and induces risk-seeking behaviour |
| 000050 |
Mahan Alavi [Canada] ; Jonathan O. Dostrovsky [Canada] ; Mojgan Hodaie [Canada] ; Andres M. Lozano [Canada] ; William D. Hutchison [Canada] | Spatial extent of beta oscillatory activity in and between the subthalamic nucleus and substantia nigra pars reticulata of Parkinson's disease patients |
| 000051 |
Patrick S. R. Davidson [Canada] ; Shaun P. Cook [États-Unis] ; Leslie Mcghan [Canada] ; Thomas Bouchard [Canada] ; Richard Camicioli [Canada] | Source memory in normal aging and Parkinson's disease |
| 000053 |
Abdul Qayuum Rana [Canada] ; Maliha Khara [Canada] ; Mansoor Wasim [Canada] ; Tahreen Dogar [Canada] ; Bashir Alenazi [Canada] ; Nour Qa'Aty [Canada] | Screening for Adhesive Capsulitis in the Timely Diagnosis of Parkinson's Disease |
| 000055 |
D. Lee [États-Unis] ; D. Y. Henriques [Canada] ; J. Snider [États-Unis] ; D. Song [États-Unis] ; H. Poizner [États-Unis] | REACHING TO PROPRIOCEPTIVELY DEFINED TARGETS IN PARKINSON'S DISEASE: EFFECTS OF DEEP BRAIN STIMULATION THERAPY |
| 000056 |
Erin R. Foster [États-Unis] ; Mark A. Mcdaniel [États-Unis] ; Nathan S. Rose [Canada] ; Peter G. Rendell [Australie] | Prospective Memory in Parkinson Disease During a Virtual Week: Effects of Both Prospective and Retrospective Demands |
| 000059 |
JI HYUN KO [Canada] ; Francesca Antonelli [Canada] ; Oury Monchi [Canada] ; Nicola Ray [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Anthony E. Lang [Canada] ; Leigh Christopher [Canada] ; Antonio P. Strafella [Canada] | Prefrontal Dopaminergic Receptor Abnormalities and Executive Functions in Parkinson's Disease |
| 000060 |
Abdul Qayyum Rana [Canada] ; Ishraq Siddiqui [Canada] ; Masood Zangeneh [Canada] ; Abdul Fattah [Canada] ; Naeem Awan [Canada] ; Muhammad Saad Yousuf [Canada] | Predicting treatment-seeking for visual hallucinations among Parkinson's disease patients |
| 000061 |
Bogdan Neagu [Canada] ; Eric Tsang [Canada] ; Filomena Mazzella [Canada] ; Clement Hamani [Canada] ; Elena Moro [Canada] ; Mojgan Hodaie [Canada] ; Andres M. Lozano [Canada] ; Robert Chen [Canada] | Pedunculopontine nucleus evoked potentials from subthalamic nucleus stimulation in Parkinson's disease |
| 000062 |
Sakineh Akram [Canada] ; James S. Frank [Canada] ; Mandar Jog [Canada] | Parkinson's Disease and Segmental Coordination during Turning: II. Walking Turns |
| 000063 |
Sakineh Akram [Canada] ; James S. Frank [Canada] ; Mandar Jog [Canada] | Parkinson's Disease and Segmental Coordination during Turning: I. Standing Turns |
| 000064 |
Brit Mollenhauer [Allemagne] ; Ellen Trautmann [Allemagne] ; Friederike Sixel-Döring [Allemagne] ; Tamara Wicke [Allemagne] ; Jens Ebentheuer [Allemagne] ; Martina Schaumburg [Allemagne] ; Elisabeth Lang [Allemagne] ; Niels K. Focke [Allemagne] ; Kishore R. Kumar [Allemagne] ; Katja Lohmann [Allemagne] ; Christine Klein [Allemagne] ; Michael G. Schlossmacher [Canada] ; Ralf Kohnen [Allemagne] ; Tim Friede [Allemagne] ; Claudia Trenkwalder [Allemagne] | Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort |
| 000065 |
Susan H. Fox [Canada] | Non-dopaminergic Treatments for Motor Control in Parkinson's Disease |
| 000066 |
Leigh Christopher [Canada] ; Antonio P. Strafella [Canada] | Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease |
| 000068 |
Danielle Murray [Canada] ; A. Jon Stoessl [Canada] | Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions |
| 000069 |
Nathan Herrmann [Canada] ; Connie Marras [Canada] ; Hadas D. Fischer [Canada] ; XUESONG WANG [Canada] ; Geoff M. Anderson [Canada] ; Paula A. Rochon [Canada] | Management of Neuropsychiatric Symptoms in Long-Term Care Residents with Parkinson's Disease: A Retrospective Cohort Study |
| 000070 |
E. Florin [Allemagne, Canada] ; H. S. Dafsari [Allemagne] ; C. Reck [Allemagne] ; M. T. Barbe [Allemagne] ; K. A. M. Pauls [Allemagne] ; M. Maarouf [Allemagne] ; V. Sturm [Allemagne] ; G. R. Fink [Allemagne] ; L. Timmermann [Allemagne] | MODULATION OF LOCAL FIELD POTENTIAL POWER OF THE SUBTHALAMIC NUCLEUS DURING ISOMETRIC FORCE GENERATION IN PATIENTS WITH PARKINSON'S DISEASE |
| 000072 |
Cristina Nombela [Royaume-Uni] ; Laura E. Hughes [Royaume-Uni] ; Adrian M. Owen [Canada] ; Jessica A. Grahn [Canada] | Into the groove: Can rhythm influence Parkinson's disease? |
| 000073 |
ZHEN NI [Canada] ; Nina Bahl [Canada] ; Carolyn A. Gunraj [Canada] ; Filomena Mazzella [Canada] ; Robert Chen [Canada] | Increased motor cortical facilitation and decreased inhibition in Parkinson disease |
| 000074 |
David Mongeon [Canada] ; Pierre Blanchet [Canada] ; Julie Messier [Canada] | Impact of Parkinson's disease and dopaminergic medication on adaptation to explicit and implicit visuomotor perturbations |
| 000075 |
William Reginold [Canada] ; Sarah Duff-Canning [Canada] ; Christopher Meaney [Canada] ; Melissa J. Armstrong [Canada] ; Susan Fox [Canada] ; Brandon Rothberg [Canada] ; Cindy Zadikoff [États-Unis] ; Nancy Kennedy [États-Unis] ; David Gill [États-Unis] ; Paul Eslinger [États-Unis] ; Fred Marshall [États-Unis] ; Mark Mapstone [États-Unis] ; Kelvin L. Chou [États-Unis] ; Carol Persad [États-Unis] ; Irene Litvan [États-Unis] ; Benjamin Mast [États-Unis] ; David Tang-Wai [Canada] ; Anthony E. Lang [Canada] ; Connie Marras [Canada] | Impact of Mild Cognitive Impairment on Health-Related Quality of Life in Parkinson's Disease |
| 000076 |
M. Anne Harris [Canada] ; HUI SHEN [Canada] ; Stephen A. Marion [Canada] ; Joseph K. C. Tsui [Canada] ; Kay Teschke [Canada] | Head injuries and Parkinson's disease in a case-control study |
| 000078 |
Ned Jenkinson [Royaume-Uni] ; Andrea A. Kühn [Allemagne] ; Peter Brown [Royaume-Uni] | Gamma oscillations in the human basal ganglia |
| 000081 |
Alexander M. Crizzle [Canada] ; Anita M. Myers [Canada] | Examination of naturalistic driving practices in drivers with Parkinson's disease compared to age and gender-matched controls |
| 000082 |
Maria Gabriela Sanchez [Canada] ; Marc Morissette [Canada] ; Thérèse Di Paolo [Canada] | Estradiol and brain serotonin reuptake transporter in long-term ovariectomized parkinsonian monkeys |
| 000083 |
Alexander C. Sutton [États-Unis] ; Wilson Yu [États-Unis] ; Megan E. Calos [États-Unis] ; Lauren E. Mueller [États-Unis] ; Matthew Berk [États-Unis] ; Jenny Shim [États-Unis] ; Eric S. Molho [États-Unis] ; Jonathan M. Brotchie [Canada] ; Peter L. Carlen [Canada] ; Damian S. Shin [États-Unis] | Elevated potassium provides an ionic mechanism for deep brain stimulation in the hemiparkinsonian rat |
| 000084 |
Fariborz Rahimi [Royaume-Uni] ; Carina Bee [Royaume-Uni] ; Derek Debicki [Canada] ; Angela C. Roberts [Canada] ; Priya Bapat [Canada] ; Mandar Jog [Royaume-Uni, Canada] | Effectiveness of BoNT A in Parkinson's Disease Upper Limb Tremor Management |
| 000085 |
Kaylena A. Ehgoetz Martens [Canada] ; Colin G. Ellard [Canada] ; Quincy J. Almeida [Canada] | Dopaminergic contributions to distance estimation in Parkinson's disease: A sensory-perceptual deficit? |
| 000086 |
Scott Mackey [États-Unis, Canada] ; YU JING [République populaire de Chine, Canada] ; Joseph Flores [Suède, Canada] ; Katie Dinelle [Canada] ; Doris J. Doudet [Canada] | Direct intranigral administration of an ubiquitin proteasome system inhibitor in rat: Behavior, positron emission tomography, immunohistochemistry |
| 000087 |
Jolyn N. A. D'Andrea [Canada] ; Angela M. Haffenden [Canada] ; Sarah Furtado [Canada] ; Oksana Suchowersky [Canada] ; Bradley G. Goodyear [Canada] | Degradation of stored movement representations in the parkinsonian brain and the impact of levodopa |
| 000088 |
Lily R. Aleksandrova [Canada] ; Meaghan C. Creed [Canada] ; Paul J. Fletcher [Canada] ; Daniela S. S. Lobo [Canada] ; Clement Hamani [Canada] ; José N. Nobrega [Canada] | Deep brain stimulation of the subthalamic nucleus increases premature responding in a rat gambling task |
| 000089 |
Madeleine E. Sharp [Canada] ; Jayalakshmi Viswanathan [Canada] ; Martin J. Mckeown [Canada] ; Silke Appel-Cresswell [Canada] ; A. Jon Stoessl [Canada] ; Jason J. S. Barton [Canada] | Decisions under risk in Parkinson's disease: Preserved evaluation of probability and magnitude |
| 000090 |
E. Florin [Allemagne, Canada] ; R. Erasmi [Allemagne] ; C. Reck [Allemagne] ; M. Maarouf [Allemagne] ; A. Schnitzler [Allemagne] ; G. R. Fink [Allemagne] ; L. Timmermann [Allemagne] | DOES INCREASED GAMMA ACTIVITY IN PATIENTS SUFFERING FROM PARKINSON'S DISEASE COUNTERACT THE MOVEMENT INHIBITING BETA ACTIVITY? |
| 000093 |
Edward Stein [Israël] ; Izhar Bar-Gad [Israël] | Beta oscillations in the cortico-basal ganglia loop during parkinsonism |
| 000095 |
Christopher Kobylecki [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni, Canada] | Alternative splicing of AMPA receptor subunits in the 6-OHDA-lesioned rat model of Parkinson's disease and L-DOPA-induced dyskinesia |
| 000096 |
Alberto Priori [Italie] ; Guglielmo Foffani [Espagne, États-Unis] ; Lorenzo Rossi [Italie] ; Sara Marceglia [Italie] | Adaptive deep brain stimulation (aDBS) controlled by local field potential oscillations |
| 000098 |
XUN CHEN [Canada] ; XIANG CHEN [République populaire de Chine] ; Rabab Kreidieh Ward [Canada] ; Z. Jane Wang [Canada] | A Joint Multimodal Group Analysis Framework for Modeling Corticomuscular Activity : MULTIMODAL BIOMEDICAL IMAGING: ALGORITHMS AND APPLICATIONS |
| 000099 |
Joël Macoir [Canada] ; Marion Fossard [Suisse] ; Noémie Auclair Ouellet [Canada] | Les troubles morphologiques flexionnels dans la maladie de Parkinson: origine procédurale et/ou exécutive? |
| 000100 |
Shady Rahayel [Canada] ; Johannes Frasnelli [Canada] | L'odorat dans les maladies d'Alzheimer et de Parkinson : Les cinq sens dessus dessous |
| 000103 |
Sandra Noble [Canada] ; Abid Ismail [Canada] ; Rafael Godoy [Canada] ; YANWEI XI [Canada] ; Marc Ekker [Canada] | Zebrafish Parla- and Parlb-deficiency affects dopaminergic neuron patterning and embryonic survival |
| 000104 |
WEI SONG [Canada] ; Hillel Zukor [Canada] ; Shih-Hsiung Lin [Canada] ; Adrienne Liberman [Canada] ; Ayda Tavitian [Canada] ; Jeannie Mui [Canada] ; Hojatollah Vali [Canada] ; Carine Fillebeen [Canada] ; Kostas Pantopoulos [Canada] ; Ting-Di Wu [France] ; Jean-Luc Guerquin-Kern [France] ; Hyman M. Schipper [Canada] | Unregulated brain iron deposition in transgenic mice over-expressing HMOX1 in the astrocytic compartment |
| 000105 |
K. Y. Chu [Canada] ; H. Li [Canada] ; K. Wada [Japon] ; J. D. Johnson [Canada] | Ubiquitin C-terminal hydrolase L1 is required for pancreatic beta cell survival and function in lipotoxic conditions |
| 000106 |
Pei-Chen Lee [Canada] ; Yvette Bordelon [États-Unis] ; Jeff Bronstein [États-Unis] ; Beate Ritz [Canada, États-Unis] | Traumatic brain injury, paraquat exposure, and their relationship to Parkinson disease |
| 000107 |
Matthew B. Stern [États-Unis] ; Anthony Lang [Canada] ; Werner Poewe [Autriche] | Toward a Redefinition of Parkinson's Disease |
| 000108 |
Alexander Klein [Royaume-Uni] ; Lori-Ann R. Sacrey [Canada] ; Ian Q. Whishaw [Canada] ; Stephen B. Dunnett [Royaume-Uni] | The use of rodent skilled reaching as a translational model for investigating brain damage and disease |
| 000109 |
Kurt Kimpinski [Canada] ; Valeria Iodice [Royaume-Uni] ; Duane D. Burton [États-Unis] ; Michael Camilleri [États-Unis] ; Brian P. Mullan [États-Unis] ; Axel Lipp [Allemagne] ; Paola Sandroni [États-Unis] ; Tonette L. Gehrking [États-Unis] ; David M. Sletten [États-Unis] ; J. E. Ahlskog [États-Unis] ; Robert D. Fealey [États-Unis] ; Wolfgang Singer [États-Unis] ; Phillip A. Low [États-Unis] | The role of autonomic testing in the differentiation of Parkinson's disease from multiple system atrophy |
| 000110 |
Patricia Knobl [Canada] ; Lauren Kielstra [Canada] ; Quincy Almeida [Canada] | The relationship between motor planning and freezing of gait in Parkinson's disease |
| 000111 |
R. B. Laprairie [Canada] ; M. E. M. Kelly [Canada] ; E. M. Denovan-Wright [Canada] | The dynamic nature of type 1 cannabinoid receptor (CB1) gene transcription : Cannabinoids 2012 |
| 000112 |
Wei-Ju Lee [Taïwan] ; Chia-Fen Tsai [Taïwan] ; Serge Gauthier [Canada] ; Shuu-Jiun Wang [Taïwan] ; Jong-Ling Fuh [Taïwan] | The association between cognitive impairment and neuropsychiatric symptoms in patients with Parkinson's disease dementia |
| 000113 |
William Reginold [Canada] ; Melissa J. Armstrong [Canada] ; Sarah Duff-Canning [Canada] ; Anthony Lang [Canada] ; David Tang-Wai [Canada] ; Susan Fox [Canada] ; Brandon Rothberg [Canada] ; Cindy Zadikoff [États-Unis] ; Nancy Kennedy [États-Unis] ; David Gill [États-Unis] ; Paul Eslinger [États-Unis] ; Mark Mapstone [États-Unis] ; Kelvin Chou [États-Unis] ; Carol Persad [États-Unis] ; Irene Litvan [États-Unis] ; Benjamin Mast [États-Unis] ; Connie Marras [Canada] | The Pill Questionnaire in a Nondemented Parkinson's Disease Population |
| 000114 |
Nicola J. Ray [Canada] ; Antonio P. Strafella [Canada] | The Neurobiology and Neural Circuitry of Cognitive Changes in Parkinson's Disease Revealed by Functional Neuroimaging |
| 000115 |
D. Domenger [Canada] ; D. Dea [Canada] ; L. Theroux [Canada] ; L. Moquin [Canada] ; A. Gratton [Canada] ; J. Poirier [Canada] | The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain |
| 000116 |
Christian Pifl [Autriche] ; Stephen J. Kish [Canada] ; Oleh Hornykiewicz [Autriche] | Thalamic Noradrenaline in Parkinson's Disease: Deficits Suggest Role in Motor and Non-Motor Symptoms |
| 000117 |
Valérie Cochen De Cock [France] ; Sophie Bayard [France] ; HUAN YU [France, République populaire de Chine] ; Magda Grini [France] ; Bertrand Carlander [France] ; Ron Postuma [Canada] ; Mahmoud Charif [France] ; Yves Dauvilliers [France] | Suggested Immobilization Test for Diagnosis of Restless Legs Syndrome in Parkinson's Disease |
| 000118 |
E. W. Tsang [Canada] ; C. Hamani [Canada] ; E. Moro [Canada] ; F. Mazzella [Canada] ; U. Saha [Canada] ; A. M. Lozano [Canada] ; M. Hodaie [Canada] ; R. Chuang [Canada] ; T. Steeves [Canada] ; S. Y. Lim [Canada, Malaisie] ; B. Neagu [Canada] ; R. Chen [Canada] | Subthalamic deep brain stimulation at individualized frequencies for Parkinson disease |
| 000119 |
Samuel M. Goldman [États-Unis] ; Patricia J. Quinlan [États-Unis] ; G. Webster Ross [États-Unis] ; Connie Marras [Canada] ; Cheryl Meng [États-Unis] ; Grace S. Bhudhikanok [États-Unis] ; Kathleen Comyns [États-Unis] ; Monica Korell [États-Unis] ; Anabel R. Chade [Argentine] ; Meike Kasten [Allemagne] ; Benjamin Priestley [États-Unis] ; Kelvin L. Chou [États-Unis] ; Hubert H. Fernandez [États-Unis] ; Franca Cambi [États-Unis] ; J. William Langston [États-Unis] ; Caroline M. Tanner [États-Unis] | Solvent Exposures and Parkinson Disease Risk in Twins |
| 000123 |
Abdul Qayyum Rana [Canada] ; Haris Munirvaid [Canada] ; Adnaan Edun [Canada] ; Okan D [Turquie] ; Mohammed A. Rana [Canada] | Relationship of dementia and visual hallucinations in tremor and non-tremor dominant Parkinson's disease |
| 000125 |
Silvia Rios Romenets [Canada] ; Jean-Francois Gagnon [Canada] ; Véronique Latreille [Canada] ; Michel Panniset [Canada] ; Sylvain Chouinard [Canada] ; Jacques Montplaisir [Canada] ; Ronald B. Postuma [Canada] | Rapid Eye Movement Sleep Behavior Disorder and Subtypes of Parkinson's Disease |
| 000126 |
Ronald B. Postuma [Canada] ; Josie-Anne Bertrand [Canada] ; Jacques Montplaisir [Canada] ; Catherine Desjardins [Canada] ; Mélanie Vendette [Canada] ; Silvia Rios Romenets [Canada] ; Michel Panisset [Canada] ; Jean-François Gagnon [Canada] | Rapid Eye Movement Sleep Behavior Disorder and Risk of Dementia in Parkinson's Disease: A Prospective Study |
| 000129 |
Kaitlyn P. Roland [Canada] ; Jennifer M. Jakobi [Canada] ; Gareth R. Jones [Canada] ; Colin Powell [Canada] | QUALITY OF LIFE AS A DETERMINANT OF FRAILTY PHENOTYPE IN COMMUNITY-DWELLING PERSONS WITH PARKINSON'S DISEASE |
| 000130 |
Abdul Qayyum Rana [Canada] ; Muhammad Saad Yousuf [Canada] ; Sughra Naz [Canada] ; Nour Qa'Aty [Canada] | Prevalence and relation of dementia to various factors in Parkinson's disease |
| 000131 |
Anthony N. Carlsen [Canada] ; Dana Maslovat [Canada] ; Ian M. Franks [Canada] | Preparation for voluntary movement in healthy and clinical populations: Evidence from startle : Neurophysiology of the Brainstem |
| 000132 |
Andrew Siderowf [États-Unis] ; Anthony E. Lang [Canada] | Premotor Parkinson's Disease: Concepts and Definitions |
| 000133 |
Andrew Lees [Royaume-Uni] ; Stanley Fahn [États-Unis] ; Karla M. Eggert [Allemagne] ; Joseph Jankovic [États-Unis] ; Anthony Lang [Canada] ; Federico Micheli [Argentine] ; M. Maral Mouradian [États-Unis] ; Wolfgang H. Oertel [Allemagne] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Eduardo Tolosa [Espagne] ; David Squillacote [États-Unis] ; Dinesh Kumar [États-Unis] | Perampanel, an AMPA Antagonist, Found to Have No Benefit in Reducing "Off" Time in Parkinson's Disease |
| 000134 |
Nico J. Diederich [Luxembourg (pays)] ; Andre Parent [Canada] | Parkinson's disease: Acquired frailty of archaic neural networks? |
| 000135 |
Lars Timmermann [Allemagne] ; Esther Florin [Allemagne, Canada] | Parkinson's disease and pathological oscillatory activity: Is the beta band the bad guy? - New lessons learned from low-frequency deep brain stimulation |
| 000136 |
Moran Weinberger [Canada] ; William D. Hutchison [Canada] ; Mahan Alavi [Canada] ; Mojgan Hodaie [Canada] ; Andres M. Lozano [Canada] ; Elena Moro [Canada] ; Jonathan O. Dostrovsky [Canada] | Oscillatory activity in the globus pallidus internus: Comparison between Parkinson's disease and dystonia |
| 000137 |
S. Al Sweidi [Canada] ; M. G. Sanchez [Canada] ; M. Bourque [Canada] ; M. Morissette [Canada] ; D. Dluzen [États-Unis] ; T. Di Paolo [Canada] | Oestrogen Receptors and Signalling Pathways: Implications for Neuroprotective Effects of Sex Steroids in Parkinson's Disease |
| 000138 |
M. Anne Harris [Canada] ; Stephen A. Marion [Canada] ; John J. Spinelli [Canada] ; Joseph K. C. Tsui [Canada] ; Kay Teschke [Canada] | Occupational Exposure to Whole-Body Vibration and Parkinson's Disease: Results From a Population-based Case-Control Study |
| 000139 |
Jana Godau [Allemagne] ; Anna Hussl [Autriche] ; Praween Lolekha [Canada] ; A. Jon Stoessl [Canada] ; Klaus Seppi [Autriche] | Neuroimaging: Current Role in Detecting Pre-Motor Parkinson's Disease |
| 000141 |
John S. Yeomans [Canada] | Muscarinic Receptors in Brain Stem and Mesopontine Cholinergic Arousal Functions |
| 000142 |
Maria C. Rodriguez-Oroz [Espagne] ; Elena Moro [Canada] ; Paul Krack [France] | Long-Term Outcomes of Surgical Therapies for Parkinson's Disease |
| 000143 |
Aron S. Buchman [États-Unis] ; Sukriti Nag [États-Unis] ; Joshua M. Shulman [États-Unis] ; Andrew S. P. Lim [Canada] ; Veronique G. J. M. Vanderhorst [États-Unis] ; Sue E. Leurgans [États-Unis] ; Julie A. Schneider [États-Unis] ; David A. Bennett [États-Unis] | Locus Coeruleus Neuron Density and Parkinsonism in Older Adults Without Parkinson's Disease |
| 000148 |
Russell C. Callaghan [Canada] ; James K. Cunningham [États-Unis] ; Jenna Sykes [Canada] ; Stephen J. Kish [Canada] | Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs |
| 000149 |
Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Naomi P. Visanji [Canada] ; Tayyeba Darr [Canada] ; Donna Pires [Canada] ; Lili-Naz Hazrati [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada] | Increased Levels of 5-HT1A Receptor Binding in Ventral Visual Pathways in Parkinson's Disease |
| 000150 |
D. Salat-Foix [Canada] ; K. Tran [Canada] ; R. Ranawaya [Canada] ; J. Meddings [Canada] ; O. Suchowersky [Canada] | Increased Intestinal Permeability and Parkinson Disease Patients: Chicken or Egg? |
| 000151 |
Andreas R. Kupsch [Allemagne] ; Nin Bajaj [Royaume-Uni] ; Frederick Weiland [États-Unis] ; Antonio Tartaglione [Italie] ; Susanne Klutmann [Allemagne] ; Melanie Buitendyk [Canada] ; Paul Sherwin [États-Unis] ; Ann Tate [États-Unis] ; Igor D. Grachev [États-Unis] | Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study |
| 000152 |
Ronald B. Postuma [Canada] ; Dag Aarsland [Norvège] ; Paolo Barone [Italie] ; David J. Burn [Royaume-Uni] ; Christopher H. Hawkes [Royaume-Uni] ; Wolfgang Oertel [Allemagne] ; Tjalf Ziemssen [Allemagne] | Identifying Prodromal Parkinson's Disease: Pre-Motor Disorders in Parkinson's Disease |
| 000154 |
QIAN XU [Canada, République populaire de Chine] ; HONGLING GUO [Canada] ; XIAOJIE ZHANG [Canada] ; BEISHA TANG [République populaire de Chine] ; FANG CAI [Canada] ; WEIHUI ZHOU [République populaire de Chine] ; WEIHONG SONG [Canada, République populaire de Chine] | Hypoxia regulation of ATP13A2 (PARK9) gene transcription |
| 000156 |
R. B. Postuma [Canada] ; A. E. Lang [Canada] ; J. F. Gagnon [Canada] ; A. Pelletier [Canada] ; J. Y. Montplaisir [Canada] | How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder |
| 000158 |
Samuel M. Goldman [États-Unis] ; Freya Kamel [États-Unis] ; G. Webster Ross [États-Unis] ; Sarah A. Jewell [États-Unis, Allemagne] ; Grace S. Bhudhikanok [États-Unis] ; David Umbach [États-Unis] ; Connie Marras [Canada] ; Robert A. Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; Stewart A. Factor [États-Unis] ; Susan Bressman [États-Unis] ; Kelly E. Lyons [États-Unis] ; Cheryl Meng [États-Unis] ; Monica Korell [États-Unis] ; Diana F. Roucoux [États-Unis] ; Jane A. Hoppin [États-Unis] ; Dale P. Sandler [États-Unis] ; J. William Langston [États-Unis] ; Caroline M. Tanner [États-Unis] | Head Injury, Alpha-Synuclein Rep1, and Parkinson's Disease |
| 000159 |
Per Borghammer [Danemark] ; S Ren B. Hansen [Danemark] ; Carsten Eggers [Allemagne] ; Mallar Chakravarty [Canada] ; KIM VANG [Danemark] ; Joel Aanerud [Danemark] ; Rüdiger Hilker [Allemagne] ; Wolf-Dieter Heiss [Allemagne] ; Anders Rodell [Danemark] ; Ole L. Munk [Danemark] ; David Keator [États-Unis] ; Albert Gjedde [Danemark] | Glucose metabolism in small subcortical structures in Parkinson's disease |
| 000160 |
Samuel M. Goldman [États-Unis] ; Freya Kamel [États-Unis] ; G. Webster Ross [États-Unis] ; Grace S. Bhudhikanok [États-Unis] ; Jane A. Hoppin [États-Unis] ; Monica Korell [États-Unis] ; Connie Marras [Canada] ; Cheryl Meng [États-Unis] ; David M. Umbach [États-Unis] ; Meike Kasten [Allemagne] ; Anabel R. Chade [Argentine] ; Kathleen Comyns [États-Unis] ; Marie B. Richards [États-Unis] ; Dale P. Sandler [États-Unis] ; Aaron Blair [États-Unis] ; J. William Langston [États-Unis] ; Caroline M. Tanner [États-Unis] | Genetic Modification of the Association of Paraquat and Parkinson's Disease |
| 000161 |
I. Rektorova [République tchèque] ; M. Mikl [République tchèque] ; J. Barrett [Canada] ; R. Marecek [République tchèque] ; I. Rektor [République tchèque] ; T. Paus [Canada] | Functional neuroanatomy of vocalization in patients with Parkinson's disease |
| 000162 |
Connie Marras [Canada] ; Katja Lohmann [Allemagne] ; Anthony Lang [Canada] ; Christine Klein [Allemagne] | Fixing the broken system of genetic locus symbols: Parkinson disease and dystonia as examples |
| 000164 |
D. W. Luchtman [Canada] ; Q. Meng [Canada] ; C. Song [Canada, République populaire de Chine] | Ethyl-eicosapentaenoate (E-EPA) attenuates motor impairments and inflammation in the MPTP-probenecid mouse model of Parkinson's disease |
| 000166 |
David J. Pedrosa [Allemagne] ; Christiane Reck [Allemagne] ; Esther Florin [Allemagne, Canada] ; K. Amande M. Pauls [Allemagne] ; Mohammad Maarouf [Allemagne] ; Lars Wojtecki [Allemagne] ; Haidar Salimi Dafsari [Allemagne] ; Volker Sturm [Allemagne] ; Alfons Schnitzler [Allemagne] ; Gereon R. Fink [Allemagne] ; Lars Timmermann [Allemagne] | Essential tremor and tremor in Parkinson's disease are associated with distinct 'tremor clusters' in the ventral thalamus |
| 000167 |
Olena Babenko [Canada] ; Igor Kovalchuk [Canada] ; Gerlinde A. Metz [Canada] | Epigenetic programming of neurodegenerative diseases by an adverse environment |
| 000170 |
Orit Zamir [Canada] ; Carolyn Gunraj [Canada] ; ZHEN NI [Canada] ; Filomena Mazzella [Canada] ; Robert Chen [Canada] | Effects of theta burst stimulation on motor cortex excitability in Parkinson's disease |
| 000172 |
Elaine M. Dennison [Royaume-Uni, Nouvelle-Zélande] ; Juliet E. Compston [Royaume-Uni] ; Julie Flahive [États-Unis] ; Ethel S. Siris [États-Unis] ; Stephen H. Gehlbach [États-Unis] ; Jonathan D. Adachi [Canada] ; Steven Boonen [Belgique] ; Roland Chapurlat [France] ; Adolfo Diez-Perez [Espagne] ; Frederick A. Jr Anderson [États-Unis] ; Frederick H. Hooven [États-Unis] ; Andrea Z. Lacroix [États-Unis] ; Robert Lindsay [États-Unis] ; J. Coen Netelenbos [Pays-Bas] ; Johannes Pfeilschifter [Allemagne] ; Maurizio Rossini [Italie] ; Christian Roux [France] ; Kenneth G. Saag [États-Unis] ; Philip Sambrook [Australie] ; Stuart Silverman [États-Unis] ; Nelson B. Watts [États-Unis] ; Susan L. Greenspan [États-Unis] ; Melissa Premaor ; Cyrus Cooper [Royaume-Uni] | Effect of co-morbidities on fracture risk: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW) |
| 000173 |
Golnasim Riahi [Canada] ; Marc Morissette [Canada] ; Daniel Levesque [Canada] ; Claude Rouillard [Canada] ; Pershia Samadi [Canada] ; Martin Parent [Canada] ; Thérèse Di Paolo [Canada] | Effect of chronic L-DOPA treatment on 5-HT1A receptors in parkinsonian monkey brain |
| 000175 |
S. Al-Sweidi [Canada] ; M. Morissette [Canada] ; T. Di Paolo [Canada] | Effect of Oestrogen Receptors on Brain NMDA Receptors of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mice |
| 000176 |
Julia Sacher [Canada, Allemagne] ; Eugenii A. Rabiner [Canada] ; Michael Clark [Canada] ; Pablo Rusjan [Canada] ; Alexandra Soliman [Canada] ; Rada Boskovic [Canada] ; Stephen J. Kish [Canada] ; Alan A. Wilson [Canada] ; Sylvain Houle [Canada] ; Jeffrey H. Meyer [Canada] | Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [11C]-harmine positron emission tomography study |
| 000177 |
Bernard Ravina [États-Unis] ; Kenneth Marek [États-Unis] ; Shirley Eberly [États-Unis] ; David Oakes [États-Unis] ; Roger Kurlan [États-Unis] ; Alberto Ascherio [États-Unis] ; Flint Beal [États-Unis] ; James Beck [États-Unis] ; Emily Flagg [États-Unis] ; Wendy R. Galpern [États-Unis] ; Jennifer Harman [États-Unis] ; Anthony E. Lang [Canada] ; Michael Schwarzschild [États-Unis] ; Caroline Tanner [États-Unis] ; Ira Shoulson [États-Unis] | Dopamine Transporter Imaging Is Associated With Long-Term Outcomes in Parkinson's Disease |
| 000178 |
Aimee J. Nelson [Canada] ; Azra Premji [Canada] ; Navjot Rai [Canada] ; Tasnuva Hoque [Canada] ; Mark Tommerdahl [États-Unis] ; Robert Chen [Canada] | Dopamine Alters Tactile Perception in Parkinson's Disease |
| 000179 |
Bruno Dubois [France] ; Eduardo Tolosa [Espagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew J. Lees [Royaume-Uni] ; Gunther Schumann [Allemagne] ; Emmanuelle Pourcher [Canada] ; Julian Gray [Suisse] ; Gail Thomas [Royaume-Uni] ; Jina Swartz [Royaume-Uni] ; Timothy Hsu [États-Unis] ; Margaret L. Moline [États-Unis] | Donepezil in Parkinson's Disease Dementia: A Randomized, Double-Blind Efficacy and Safety Study |
| 000180 |
Kaylena A. Ehgoetz Martens [Canada] ; Quincy J. Almeida [Canada] | Dissociating Between Sensory and Perceptual Deficits in PD: More Than Simply a Motor Deficit |
| 000183 |
Pierre J. Blanchet [Canada] ; Louise Normandeau [Canada] ; Pierre H. Rompre [Canada] | Comparing three screening tools for drug-induced parkinsonism in patients with advanced schizophrenia: A pilot study |
| 000184 |
Rena K. Mann [Canada] ; Roderick Edwards [Canada] ; JULIE ZHOU [Canada] ; Alison Fenney [Canada] ; Mandar Jog [Canada] ; Christian Duval [Canada] | Comparing movement patterns associated with Huntington's chorea and Parkinson's dyskinesia |
| 000186 |
Josie-Anne Bertrand [Canada] ; Christophe Bedetti [Canada] ; Ronald B. Postuma [Canada] ; Oury Monchi [Canada] ; Daphne Génier Marchand [Canada] ; Thomas Jubault [Canada] ; Jean-François Gagnon [Canada] | Color Discrimination Deficits in Parkinson's Disease are Related to Cognitive Impairment and White-Matter Alterations |
| 000187 |
Evelyne Matteau [Canada] ; Nicolas Dupre [Canada] ; Mélanie Langlois [Canada] ; Pierre Provencher [Canada] ; Martine Simard [Canada] | Clinical Validity of the Mattis Dementia Rating Scale-2 in Parkinson Disease With MCI and Dementia |
| 000188 |
Abdul Qayyum Rana [Canada] ; Ishraq Siddiqui [Canada] ; Muhammad Saad Yousuf [Canada] | Challenges in diagnosis of young onset Parkinson's disease |
| 000190 |
Ronald B. Postuma [Canada] ; Anthony E. Lang [Canada] ; Renato P. Munhoz [Brésil] ; Katia Charland [Canada] ; Amelie Pelletier [Canada] ; Mariana Moscovich [Brésil] ; Luciane Filla [Brésil] ; Debora Zanatta [Brésil] ; Silvia Rios Romenets [Canada] ; Robert Altman [Canada] ; Rosa Chuang [Canada] ; Binit Shah [Canada] | Caffeine for treatment of Parkinson disease: A randomized controlled trial |
| 000191 |
Jihane Ismaili [Canada] ; Martin Boisvert [Canada] ; Fanny Longpre [Canada] ; Julie Carange [Canada] ; Céline Le Gall [Canada] ; Maria-Grazia Martinoli [Canada] ; Benoit Daoust [Canada] | Brassinosteroids and analogs as neuroprotectors: Synthesis and structure-activity relationships |
| 000192 |
Mélanie Vendette [Canada] ; Jacques Montplaisir [Canada] ; Nadia Gosselin [Canada] ; Jean-Paul Soucy [Canada] ; Ronald B. Postuma [Canada] ; Thien Thanh Dang-Vu [Canada, Belgique] ; Jean-François Gagnon [Canada] | Brain Perfusion Anomalies in Rapid Eye Movement Sleep Behavior Disorder with Mild Cognitive Impairment |
| 000194 |
M. Anne Harris [Canada] ; Joseph K. Tsui [Canada] ; Stephen A. Marion [Canada] ; HUI SHEN [Canada] ; Kay Teschke [Canada] | Association of Parkinson's Disease With Infections and Occupational Exposure to Possible Vectors |
| 000197 |
YILONG MA [États-Unis] ; SHUCHUN PENG [États-Unis] ; Phoebe G. Spetsieris [États-Unis] ; Vesna Sossi [Canada] ; David Eidelberg [États-Unis] ; Doris J. Doudet [Canada] | Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism |
| 000198 |
I. H. Richard [États-Unis] ; M. P. Mcdermott [États-Unis] ; R. Kurlan [États-Unis] ; J. M. Lyness [États-Unis] ; P. G. Como [États-Unis] ; N. Pearson [États-Unis] ; S. A. Factor [États-Unis] ; J. Juncos [États-Unis] ; C. Serrano Ramos [États-Unis] ; M. Brodsky [États-Unis] ; C. Manning [États-Unis] ; L. Marsh [États-Unis] ; L. Shulman [États-Unis] ; H. H. Fernandez [États-Unis] ; K. J. Black [États-Unis] ; M. Panisset [Canada] ; C. W. Christine [États-Unis] ; W. Jiang [États-Unis] ; C. Singer [États-Unis] ; S. Horn [États-Unis] ; R. Pfeiffer [États-Unis] ; D. Rottenberg [États-Unis] ; J. Slevin [États-Unis] ; L. Elmer [États-Unis] ; D. Press [États-Unis] ; H. C. Hyson [Canada] ; W. Mcdonald [États-Unis] | A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease |
| 000199 |
Olivier Rascol [France] ; Joaquim Ferreira [Portugal] ; Laurence Negre-Pages [France] ; Santiago Perez-Lloret [France] ; Lucette Lacomblez [France] ; Monique Galitzky [France] ; Jean-Christophe Lemarie [France] ; Jean-Christophe Corvol [France] ; Jonathan M. Brotchie [Canada] ; Laura Bossi [France] | A proof-of-concept, randomized, placebo-controlled, multiple cross-overs (n-of-1) study of naftazone in Parkinson's disease |
| 000202 |
Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; QIN LI [République populaire de Chine] ; Jonathan Brotchie [Canada] ; Erwan Bezard [République populaire de Chine, France] | A Critique of Available Scales and Presentation of the Non-Human Primate Dyskinesia Rating Scale |
| 000203 |
C. Paquette [États-Unis] ; E. Franzen [États-Unis, Suède] ; G. M. Jones [Canada] ; F. B. Horak [États-Unis] | WALKING IN CIRCLES: NAVIGATION DEFICITS FROM PARKINSON'S DISEASE BUT NOT FROM CEREBELLAR ATAXIA |
| 000204 |
Richard Camicioli [Canada] ; Jennifer Sabino [Canada] ; Myrlene Gee [Canada] ; Thomas Bouchard [Canada] ; Nancy Fisher [Canada] ; Chris Hanstock [Canada] ; Derek Emery [Canada] ; W. R. Wayne Martin [Canada] | Ventricular Dilatation and Brain Atrophy in Patients with Parkinson's Disease with Incipient Dementia |
| 000206 |
Sylvia Villeneuve [Canada] ; Jessica Rodrigues-Brazete [Canada] ; Steve Joncas [Canada] ; Ronald B. Postuma [Canada] ; Véronique Latreille [Canada] ; Jean-François Gagnon [Canada] | Validity of the Mattis Dementia Rating Scale to Detect Mild Cognitive Impairment in Parkinson's Disease and REM Sleep Behavior Disorder |
| 000207 |
Carles Vilarino-Güell [Canada] ; Christian Wider [Suisse] ; Owen A. Ross [États-Unis] ; Justus C. Dachsel [États-Unis] ; Jennifer M. Kachergus [États-Unis] ; Sarah J. Lincoln [États-Unis] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Stephanie A. Cobb [États-Unis] ; Greggory J. Wilhoite [États-Unis] ; Justin A. Bacon [États-Unis] ; Bahareh Behrouz [États-Unis] ; Heather L. Melrose [États-Unis] ; Emna Hentati [États-Unis] ; Andreas Puschmann [États-Unis, Suède] ; Daniel M. Evans [Canada] ; Elizabeth Conibear [Canada] ; Wyeth W. Wasserman [Canada] ; Jan O. Aasly [Norvège] ; Pierre R. Burkhard [Suisse] ; Ruth Djaldetti [Israël] ; Joseph Ghika [Suisse] ; Faycal Hentati [Tunisie] ; Anna Krygowska-Wajs [Pologne] ; Tim Lynch [Irlande (pays)] ; Eldad Melamed [Israël] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Alessandra Solida [Suisse] ; Ruey-Meei Wu [Taïwan] ; Ryan J. Uitti [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; François Vingerhoets [Suisse] ; Matthew J. Farrer [Canada, États-Unis] | VPS35 Mutations in Parkinson Disease |
| 000208 |
Elena Moro [Canada] ; Jason M. Schwalb [Canada, États-Unis] ; Panida Piboolnurak [Canada, États-Unis] ; Yu-Yan W. Poon [Canada] ; Clement Hamani [Canada] ; Serena W. Hung [Canada, États-Unis] ; Tamara Arenovich [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada] ; Andres M. Lozano [Canada] | Unilateral subdural motor cortex stimulation improves essential tremor but not Parkinson's disease |
| 000210 |
Marie-Christine Chartier-Harlin [France] ; Justus C. Dachsel [États-Unis] ; Carles Vilarino-Güell [Canada] ; Sarah J. Lincoln [États-Unis] ; Frédéric Lepretre [France] ; Mary M. Hulihan [États-Unis] ; Jennifer Kachergus [États-Unis] ; Austen J. Milnerwood [Canada] ; Lucia Tapia [Canada] ; Mee-Sook Song [Canada] ; Emilie Le Rhun [France] ; Eugénie Mutez [France] ; Lydie Larvor [France] ; Aurélie Duflot [France] ; Christel Vanbesien-Mailliot [France] ; Alexandre Kreisler [France] ; Owen A. Ross [États-Unis] ; Kenya Nishioka [États-Unis] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Stephanie A. Cobb [États-Unis] ; Heather L. Melrose [États-Unis] ; Bahareh Behrouz [États-Unis] ; Brett H. Keeling [États-Unis] ; Justin A. Bacon [États-Unis] ; Emna Hentati [États-Unis] ; Lindsey Williams [États-Unis] ; Akiko Yanagiya [Canada] ; Nahum Sonenberg [Canada] ; Paul J. Lockhart [Australie] ; Abba C. Zubair [États-Unis] ; Ryan J. Uitti [États-Unis] ; Jan O. Aasly [Norvège] ; Anna Krygowska-Wajs [Pologne] ; Grzegorz Opala [Pologne] ; Zbigniew K. Wszolek [États-Unis] ; Roberta Frigerio ; Demetrius M. Maraganore ; David Gosal ; Tim Lynch ; Michael Hutchinson ; Anna Rita Bentivoglio ; Enza Maria Valente ; William C. Nichols ; Nathan Pankratz ; Tatiana Foroud ; Rachel A. Gibson ; Faycal Hentati ; Dennis W. Dickson [États-Unis] ; Alain Destée [France] ; Matthew J. Farrer [États-Unis, Canada] | Translation Initiator EIF4G1 Mutations in Familial Parkinson Disease |
| 000211 |
N. Auclair-Ouellet [Canada] ; S. Chantal [Canada] ; L. Cantin [Canada] ; M. Prud'Homme [Canada] ; M. Langlois [Canada] ; J. Macoir [Canada] | Transient Executive Dysfunction Following STN- DBS in Parkinson's Disease |
| 000212 |
Pascal H. H. M. Van Lieshout [Canada] ; Catriona M. Steele [Canada] ; Anthony E. Lang [Canada] | Tongue Control for Swallowing in Parkinson's Disease: Effects of Age, Rate, and Stimulus Consistency |
| 000213 |
Morris Freedman [Canada] ; Donald T. Stuss [Canada] | Theory of Mind in Parkinson's disease |
| 000214 |
Darcy Litteljohn [Canada] ; Eric Nelson [Canada] ; Cheri Bethune [Canada] ; Shawn Hayley [Canada] | The effects of paraquat on regional brain neurotransmitter activity, hippocampal BDNF and behavioural function in female mice |
| 000215 |
Penny A. Macdonald [Canada] ; Alex A. Macdonald [Canada] ; Ken N. Seergobin [Canada] ; Ruzbeh Tamjeedi [Canada] ; Hooman Ganjavi [Canada] ; Jean-Sebastien Provost [Canada] ; Oury Monchi [Canada] | The effect of dopamine therapy on ventral and dorsal striatum-mediated cognition in Parkinson's disease: support from functional MRI |
| 000216 |
James B. Koprich [Canada] ; Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; Allan Goodman [États-Unis] ; Bertrand Le Bourdonnec [États-Unis] ; Roland E. Dolle [États-Unis] ; Robert N. Dehaven [États-Unis] ; Diane L. Dehaven-Hudkins [États-Unis] ; Patrick J. Little [États-Unis] ; Jonathan M. Brotchie [Canada] | The Selective Mu-Opioid Receptor Antagonist ADL5510 Reduces Levodopa-Induced Dyskinesia Without Affecting Antiparkinsonian Action in MPTP-Lesioned Macaque Model of Parkinson's Disease |
| 000217 |
Klaus Seppi ; Daniel Weintraub ; Miguel Coelho ; Santiago Perez-Lloret ; Susan H. Fox ; Regina Katzenschlager ; Eva-Maria Hametner ; Werner Poewe [Autriche] ; Olivier Rascol ; Christopher G. Goetz ; Cristina Sampaio | The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Non-Motor Symptoms of Parkinson's Disease |
| 000218 |
Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Shen-Yang Lim [Malaisie] ; Bernard Ravina [États-Unis] ; Klaus Seppi [Autriche] ; Miguel Coelho [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal] | The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Motor Symptoms of Parkinson's Disease |
| 000219 |
Francisco A. Ponce [États-Unis] ; Andres M. Lozano [Canada] | The Most Cited Works in Parkinson's Disease |
| 000220 |
Dustin A. Heldman [États-Unis] ; Joseph P. Giuffrida [États-Unis] ; Robert Chen [Canada] ; Megan Payne [États-Unis] ; Filomena Mazzella [Canada] ; Andrew P. Duker [États-Unis] ; Alok Sahay [États-Unis] ; Sang Jin Kim [Canada] ; Fredy J. Revilla [États-Unis] ; Alberto J. Espay [États-Unis] | The Modified Bradykinesia Rating Scale for Parkinson's Disease: Reliability and Comparison with Kinematic Measures |
| 000222 |
Christine Klein [Canada, Allemagne] ; Rosalind Chuang [Canada] ; Connie Marras [Canada] ; Anthony E. Lang [Canada] | The Curious Case of Phenocopies in Families with Genetic Parkinson's Disease |
| 000223 |
Anna Castrioto [Italie, Canada] ; Andres M. Lozano [Canada] ; Yu-Yan Poon [Canada] ; Anthony E. Lang [Canada] ; Melanie Fallis [Canada] ; Elena Moro [Canada] | Ten-Year Outcome of Subthalamic Stimulation in Parkinson Disease: A Blinded Evaluation |
| 000224 |
Simon Ducharme [Canada, États-Unis] ; Alice W. Flaherty ; Stephen J. Seiner ; Darin D. Dougherty ; Oscar G. Morales | Temporary Interruption of Deep Brain Stimulation for Parkinson's Disease During Outpatient Electroconvulsive Therapy for Major Depression: A Novel Treatment Strategy |
| 000226 |
Christopher Kobylecki [Royaume-Uni] ; Michael P. Hill [Canada] ; Alan R. Crossman [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni, Canada] | Synergistic Antidyskinetic Effects of Topiramate and Amantadine in Animal Models of Parkinson's Disease |
| 000228 |
Diego Santos-Garcia [Espagne] ; Mercedes Macias [Espagne] ; Miguel Llaneza [Espagne] ; M Nica Grande [Espagne] ; Raúl De La Fuente-Fernandez [Canada] | Serum Vitamin B12 and Folate Levels in Parkinson's Disease Patients Treated with Duodenal Levodopa Infusion |
| 000229 |
Caroline M. Tanner [États-Unis] ; Freya Kamel [États-Unis] ; G. Webster Ross [États-Unis] ; Jane A. Hoppin [États-Unis] ; Samuel M. Goldman [États-Unis] ; Monica Korell [États-Unis] ; Connie Marras [Canada] ; Grace S. Bhudhikanok [États-Unis] ; Meike Kasten [Allemagne] ; Anabel R. Chade [Argentine] ; Kathleen Comyns [États-Unis] ; Marie Barber Richards [États-Unis] ; Cheryl Meng [États-Unis] ; Benjamin Priestley [États-Unis] ; Hubert H. Fernandez [États-Unis] ; Franca Cambi [États-Unis] ; David M. Umbach [États-Unis] ; Aaron Blair [États-Unis] ; Dale P. Sandler [États-Unis] ; J. William Langston [États-Unis] | Rotenone, Paraquat, and Parkinson's Disease |
| 000230 |
Jonathan Kimmelman [Canada] ; Katherine Duckworth [Canada] ; Tim Ramsay [Canada] ; Tiffini Voss [États-Unis] ; Bernard Ravina [États-Unis] ; Marina Elena Emborg [États-Unis] | Risk of Surgical Delivery to Deep Nuclei: A Meta-analysis |
| 000231 |
J. H. J. Allum [Suisse] ; K.-S. Tang [Suisse, Pays-Bas] ; M. G. Carpenter [Canada] ; L. B. Oude Nijhuis [Pays-Bas] ; B. R. Bloem [Pays-Bas] | Review of first trial responses in balance control: Influence of vestibular loss and Parkinson's disease |
| 000232 |
Jennifer G. Goldman [États-Unis] ; Darcy Marr [Canada] ; LILI ZHOU [États-Unis] ; Bichun Ouyang [États-Unis] ; Sue E. Leurgans [États-Unis] ; Elizabeth Berry-Kravis [États-Unis] ; Christopher G. Goetz [États-Unis] | Racial Differences May Influence the Role of Cholecystokinin Polymorphisms in Parkinson's Disease Hallucinations |
| 000234 |
Marianne Vaugoyeau [France] ; Hussein Hakam [France] ; Jean-Philippe Azulay [France] | Proprioceptive impairment and postural orientation control in Parkinson's disease |
| 000235 |
Connie Marras [Canada] ; Michael P. Mcdermott [États-Unis] ; Ken Marek [États-Unis] ; Paula Rochon [Canada] ; Gary Naglie [Canada] ; Caroline M. Tanner [États-Unis] ; Alice Rudolph [États-Unis] ; Ira Shoulson [États-Unis] ; Anthony E. Lang [Canada] | Predictors of Time to Requiring Dopaminergic Treatment in 2 Parkinson's Disease Cohorts |
| 000237 |
C. Gibrat [Canada] ; F. Cicchetti [Canada] | Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases : THE NEUROBIOLOGY OF NEURODEGENERATIVE DISORDER: FROM BASIC TO CLINICAL RESEARCH |
| 000238 |
Meir Plotnik [Israël] ; Nir Giladi [Israël] ; Yaacov Dagan [Israël] ; Jeffery M. Hausdorff [Israël, États-Unis] | Postural instability and fall risk in Parkinson's disease: impaired dual tasking, pacing, and bilateral coordination of gait during the "ON" medication state |
| 000239 |
C. Marras [Canada] ; B. Schuele [États-Unis] ; R. P. Munhoz [Brésil] ; E. Rogaeva [Canada] ; J. W. Langston [États-Unis] ; M. Kasten [Allemagne] ; C. Meaney [Canada] ; C. Klein [Allemagne] ; P. M. Wadia [Canada] ; S.-Y. Lim [Canada] ; R. S.-I. Chuang [Canada] ; C. Zadikof [Canada] ; T. Steeves [Canada] ; K. M. Prakash [Canada] ; R. M. A. De Bie [Canada] ; G. Adeli [Canada] ; T. Thomsen [Canada] ; K. K. Johansen [Norvège] ; H. A. Teive [Brésil] ; A. Asante [Canada] ; W. Reginold [Canada] ; A. E. Lang [Canada] | Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers |
| 000240 |
Kathrine Rugbjerg [Danemark] ; M. Anne Harris [Canada] ; HUI SHEN [Canada] ; Stephen A. Marion [Canada] ; Joseph K. C. Tsui [Canada] ; Kay Teschke [Canada] | Pesticide exposure and risk of Parkinson's disease - a population-based case-control study evaluating the potential for recall bias |
| 000241 |
Roberto Cilia [Canada, Italie] ; SANG SOO CHO [Canada] ; Thilo Van Eimeren [Canada] ; Giorgio Marotta [Italie] ; Chiara Siri [Italie] ; JI HYUN KO [Canada] ; Giovanna Pellecchia [Canada] ; Gianni Pezzoli [Italie] ; Angelo Antonini [Italie] ; Antonio P. Strafella [Canada] | Pathological Gambling in Patients with Parkinson's Disease is Associated with Fronto-Striatal Disconnection: A Path Modeling Analysis |
| 000242 |
Cristina Sampaio [Portugal] ; Juliana Bronzova [Pays-Bas] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Serge V. Van De Witte [Pays-Bas] ; Ad Theeuwes [Pays-Bas] | Pardoprunox in Early Parkinson's Disease: Results from 2 Large, Randomized Double-Blind Trials |
| 000243 |
T. Tan [Canada] ; Q. J. Almeida [Canada] ; F. Rahimi [Canada] | PROPRIOCEPTIVE DEFICITS IN PARKINSON'S DISEASE PATIENTS WITH FREEZING OF GAIT |
| 000244 |
C. K. Young [Canada] ; I. Q. Whishaw [Canada] ; B. H. Bland [Canada] | POSTERIOR HYPOTHALAMIC NUCLEUS DEEP BRAIN STIMULATION RESTORES LOCOMOTION IN RATS WITH HALOPERIDOL-INDUCED AKINESIA BUT NOT SKILLED FORELIMB USE IN PELLET REACHING AND LEVER PRESSING |
| 000245 |
T. Wichmann [États-Unis] ; J. O. Dostrovsky [Canada] | PATHOLOGICAL BASAL GANGLIA ACTIVITY IN MOVEMENT DISORDERS |
| 000251 |
JINGYUN CHEN [Canada] ; Ali R. Khan [Canada] ; Martin J. Mckeown [Canada] ; Mirza F. Beg [Canada] | Momentum-based morphometric analysis with application to Parkinson's disease |
| 000253 |
Olivier Rascol [France] ; Andres Lozano [Canada] ; Matthew Stern [États-Unis] ; Werner Poewe [Autriche] | Milestones in Parkinson's Disease Therapeutics |
| 000255 |
Moonhee Lee [Canada] ; Nattinee Jantaratnotai [Canada] ; Edith Mcgeer [Canada] ; James G. Mclarnon [Canada] ; Patrick L. Mcgeer [Canada] | Mg2+ ions reduce microglial and THP-1 cell neurotoxicity by inhibiting Ca2+ entry through purinergic channels |
| 000257 |
Ramachandiran Nandhagopal [Canada] ; Lisa Kuramoto [Canada] ; Michael Schulzer [Canada] ; Edwin Mak [Canada] ; Jacqueline Cragg [Canada] ; Jess Mckenzie [Canada] ; Siobhan Mccormick [Canada] ; Thomas J. Ruth [Canada] ; Vesna Sossi [Canada] ; Raul De La Fuente-Fernandez [Canada] ; A. Jon Stoessl [Canada] | Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease |
| 000258 |
JING GUO [République populaire de Chine] ; Jun-Kang Shen [République populaire de Chine] ; LAN WANG [République populaire de Chine] ; LI XIAO [République populaire de Chine] ; Rong-Jun Zhang [République populaire de Chine] ; Wei-Feng Luo [République populaire de Chine] ; Zhi-Gang Gong [République populaire de Chine] ; JING SUN [République populaire de Chine] ; HAN XU [République populaire de Chine] ; Pierre Sirois [Canada] ; KAI LI [République populaire de Chine] | In Vivo Evaluation of Cerebral Transplantation of Resovist-Labeled Bone Marrow Stromal Cells in Parkinson's Disease Rats Using Magnetic Resonance Imaging |
| 000259 |
Francesca Antonelli [Canada] ; Nicola Ray [Canada] ; Antonio P. Strafella [Canada] | Impulsivity and Parkinson's disease: More than just disinhibition |
| 000260 |
Valerie Voon [Royaume-Uni] ; Mandy Sohr [Allemagne] ; Anthony E. Lang [Canada] ; Marc N. Potenza [États-Unis] ; Andrew D. Siderowf [États-Unis] ; Jacqueline Whetteckey [États-Unis] ; Daniel Weintraub [États-Unis] ; Glen R. Wunderlich [Canada] ; Mark Stacy [États-Unis] | Impulse Control Disorders in Parkinson Disease: A Multicenter Case-Control Study |
| 000262 |
Andrew R. Brown [Canada] ; Michael C. Antle [Canada] ; BIN HU [Canada] ; G. Campbell Teskey [Canada] | High frequency stimulation of the subthalamic nucleus acutely rescues motor deficits and neocortical movement representations following 6-hydroxydopamine administration in rats |
| 000263 |
Anne Noreau [Canada] ; Jean-Baptiste Riviere [Canada] ; Sabrina Diab [Canada] ; Patrick A. Dion [Canada] ; Michel Panisset [Canada] ; Valérie Soland [Canada] ; Nicolas Jodoin [Canada] ; Mélanie Langlois [Canada] ; Sylvain Chouinard [Canada] ; Nicolas Dupre [Canada] ; Guy A. Rouleau [Canada] | Glucocerebrosidase Mutations in a French-Canadian Parkinson's Disease Cohort |
| 000264 |
Owen A. Ross [États-Unis] ; Karen N. Conneely [États-Unis] ; TAO WANG [États-Unis] ; Carles Vilarino-Guell [États-Unis, Canada] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Alex Rajput [Canada] ; Zbigniew K. Wszolek [États-Unis] ; Ryan J. Uitti [États-Unis] ; Elan D. Louis [États-Unis] ; Lorraine N. Clark [États-Unis] ; Matthew J. Farrer [États-Unis, Canada] ; Claudia M. Testa [États-Unis] | Genetic Variants of α-Synuclein Are Not Associated with Essential Tremor |
| 000265 |
D. Salat-Foix [Canada] ; C. N. Andrews [Canada] ; J. Meddings [Canada] ; O. Suchowersky [Canada] | Gastrointestinal Symptoms in Parkinson Disease: Clinical Aspects and Management |
| 000266 |
GUANG SHI [Canada] ; Jeffrey R. Lee [Canada] ; David A. Grimes [Canada] ; Lemuel Racacho [Canada] ; David Ye [Canada] ; Howard Yang [Canada] ; Owen A. Ross [États-Unis] ; Matthew Farrer [Canada] ; G. Angus Mcquibban [Canada] ; Dennis E. Bulman [Canada] | Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease |
| 000268 |
Kaitlyn P. Roland [Canada] ; Jennifer M. Jakobi [Canada] ; Colin Powell [Canada] ; Gareth R. Jones [Canada] | Factors related to functional independence in females with Parkinson's disease: A systematic review |
| 000269 |
Karin Wirdefeldt [Suède, États-Unis] ; Hans-Olov Adami [Suède] ; Philip Cole [États-Unis] ; Dimitrios Trichopoulos [États-Unis] ; Jack Mandel [Canada] | Epidemiology and etiology of Parkinson's disease: a review of the evidence |
| 000270 |
Edward A. Neuwelt [États-Unis] ; Björn Bauer [États-Unis] ; Christoph Fahlke [Allemagne] ; Gert Fricker [Allemagne] ; Constantino Iadecola [États-Unis] ; Damir Janigro [États-Unis] ; Luc Leybaert [Belgique] ; Zoltán Molnar [Royaume-Uni] ; Martha E. O'Donnell [États-Unis] ; John T. Povlishock [États-Unis] ; Norman R. Saunders [Australie] ; Frank Sharp [États-Unis] ; Danica Stanimirovic [Canada] ; Ryan J. Watts [États-Unis] ; Lester R. Drewes [États-Unis] | Engaging neuroscience to advance translational research in brain barrier biology |
| 000272 |
Nadia Gonzalez-Garcia [Mexique] ; Jorge L. Armony [Canada] ; Julian Soto [Mexique] ; David Trejo [Mexique] ; Marco A. Alegria [Mexique] ; Rene Drucker-Colin [Mexique] | Effects of rTMS on Parkinson's disease: a longitudinal fMRI study |
| 000274 |
James K. R. Stevenson [Canada] ; Pouria Talebifard [Canada] ; Edna Ty [Canada] ; Meeko M. K. Oishi [Canada, États-Unis] ; Martin J. Mckeown [Canada] | Dyskinetic Parkinson's disease patients demonstrate motor abnormalities off medication |
| 000275 |
Lori-Ann R. Sacrey [Canada] ; Scott G. Travis [Canada] ; Ian Q. Whishaw [Canada] | Drug treatment and familiar music aids an attention shift from vision to somatosensation in Parkinson's disease on the reach-to-eat task |
| 000276 |
Alexander Klein [Canada] ; Darryl C. Gidyk [Canada] ; Alexandra M. Shriner [Canada] ; Keri L. Colwell [Canada] ; Nadine A. Tatton [Canada] ; William G. Tatton [Canada] ; Gerlinde A. Metz [Canada] | Dose-dependent loss of motor function after unilateral medial forebrain bundle rotenone lesion in rats: A cautionary note |
| 000277 |
Tyler M. Rolheiser [Canada] ; Heather G. Fulton [Canada] ; Kimberley P. Good [Canada] ; John D. Fisk [Canada] ; J. Roger Mckelvey [Canada] ; Christophe Scherfler [Autriche] ; Naeem M. Khan [Canada] ; Ronald A. Leslie [Canada] ; Harold A. Robertson [Canada] | Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's disease |
| 000278 |
Alberto J. Espay [États-Unis] ; Joe P. Giuffrida [États-Unis] ; Robert Chen [Canada] ; Megan Payne [États-Unis] ; Filomena Mazzella [Canada] ; Emily Ounn [États-Unis] ; Jennifer E. Vaughan [États-Unis] ; Andrew P. Duker [États-Unis] ; Alok Sahay [États-Unis] ; SANG JIN KIM [Canada] ; Fredy J. Revilla [États-Unis] ; Dustin A. Heldman [États-Unis] | Differential Response of Speed, Amplitude, and Rhythm to Dopaminergic Medications in Parkinson's Disease |
| 000279 |
Ngoc-Duc Doan [Canada] ; Steve Bourgault [Canada] ; Agnieszka Dejda [Canada] ; Myriam Letourneau [Canada] ; Michel Detheux [Belgique] ; David Vaudry [Canada, France] ; Hubert Vaudry [Canada, France] ; David Chatenet [Canada] ; Alain Fournier [Canada] | Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects |
| 000280 |
Jeff M. Bronstein [États-Unis] ; Michele Tagliati [États-Unis] ; Ron L. Alterman [États-Unis] ; Andres M. Lozano [Canada] ; Jens Volkmann [Allemagne] ; Alessandro Stefani [Italie] ; Fay B. Horak [États-Unis] ; Michael S. Okun [États-Unis] ; Kelly D. Foote [États-Unis] ; Paul Krack [France] ; Rajesh Pahwa [États-Unis] ; Jaimie M. Henderson [États-Unis] ; Marwan I. Hariz [Royaume-Uni] ; Roy A. Bakay [États-Unis] ; Ali Rezai [États-Unis] ; William J. Jr Marks [États-Unis] ; Elena Moro [Canada] ; Jerrold L. Vitek [États-Unis] ; Frances M. Weaver [États-Unis] ; Robert E. Gross [États-Unis] ; Mahlon R. Delong [États-Unis] | Deep Brain Stimulation for Parkinson Disease: An Expert Consensus and Review of Key Issues |
| 000281 |
Emily Bell [Canada] ; Bruce Maxwell [Canada] ; Mary Pat Mcandrews [Canada] ; Abbas Sadikot [Canada] ; Eric Racine [Canada] | Deep Brain Stimulation and Ethics: Perspectives from a Multisite Qualitative Study of Canadian Neurosurgical Centers |
| 000282 |
Jacqueline A. Gleave [Canada] ; Troy H. Farncombe [Canada] ; Chantal Saab [Canada] ; Laurie C. Doering [Canada] | Correlative single photon emission computed tomography imaging of [123I]altropane binding in the rat model of Parkinson's |
| 000284 |
Ronald B. Postuma [Canada] ; Jacques Montplaisir [Canada] ; Paola Lanfranchi [Canada] ; Hélène Blais [Canada] ; Sylvie Rompre [Canada] ; Roberto Colombo [Italie] ; Jean-François Gagnon [Canada] | Cardiac Autonomic Denervation in Parkinson's Disease Is Linked to REM Sleep Behavior Disorder |
| 000285 |
Robert D. Altman [Canada] ; Anthony E. Lang [Canada] ; Ronald B. Postuma [Canada] | Caffeine in Parkinson's Disease: A Pilot Open-Label, Dose-Escalation Study |
| 000286 |
Melanie Vendette [Canada] ; Jean-François Gagnon [Canada] ; Jean-Paul Soucy [Canada] ; Nadia Gosselin [Canada] ; Ronald B. Postuma [Canada] ; Maria Tuineag [Canada] ; Isabelle Godin [Canada] ; Jacques Montplaisir [Canada] | Brain Perfusion and Markers of Neurodegeneration in Rapid Eye Movement Sleep Behavior Disorder |
| 000289 |
HONGLIU DING [États-Unis] ; Alison K. Sarokhan [États-Unis] ; Sarah S. Roderick [États-Unis] ; Rachit Bakshi [États-Unis] ; Nancy E. Maher [États-Unis] ; Paymon Ashourian [États-Unis] ; Caroline G. Kan [États-Unis] ; Sunny Chang [États-Unis] ; Andrea Santarlasci [États-Unis] ; Kyleen E. Swords [États-Unis] ; Bernard M. Ravina [États-Unis] ; Michael T. Hayes [États-Unis] ; U. Shivraj Sohur [États-Unis] ; Anne-Marie Wills [États-Unis] ; Alice W. F. Laherty [États-Unis] ; Vivek K. Unni [États-Unis] ; Albert Y. H. Ung [États-Unis] ; Dennis J. Selkoe [États-Unis] ; Michael A. Schwarzschild [États-Unis] ; Michael G. Schlossmacher [Canada] ; Lewis R. Sudarsky [États-Unis] ; John H. Growdon [États-Unis] ; Adrian J. Ivinson [États-Unis] ; Bradley T. Hyman [États-Unis] ; Clemens R. Scherzer [États-Unis] | Association of SNCA with Parkinson: Replication in the Harvard NeuroDiscovery Center Biomarker Study |
| 000290 |
Janusz W. Blaszczyk [Pologne] ; Renata Orawiec [Pologne] | Assessment of postural control in patients with Parkinson's disease: Sway ratio analysis |
| 000291 |
Raúl De La Fuente-Fernandez [Canada] ; Michael Schulzer [Canada] ; Lisa Kuramoto [Canada] ; Jacquelyn Cragg [Canada] ; Nandhagopal Ramachandiran [Canada] ; Wing L. Au [Canada] ; Edwin Mak [Canada] ; Jess Mckenzie [Canada] ; Siobhan Mccormick [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Chong S. Lee [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] | Age-Specific Progression of Nigrostriatal Dysfunction in Parkinson's Disease |
| 000292 |
Valerie Cullen [États-Unis] ; S. Pablo Sardi [États-Unis] ; Juliana Ng [Canada] ; You-Hai Xu [États-Unis] ; YING SUN [États-Unis] ; Julianna J. Tomlinson [Canada] ; Piotr Kolodziej [Canada] ; Ilana Kahn [États-Unis] ; Paul Saftig [Allemagne] ; John Woulfe [Canada] ; Jean-Christophe Rochet [États-Unis] ; Marcie A. Glicksman [États-Unis] ; Seng H. Cheng [États-Unis] ; Gregory A. Grabowski [États-Unis] ; Lamya S. Shihabuddin [États-Unis] ; Michael G. Schlossmacher [États-Unis, Canada] | Acid β-Glucosidase Mutants Linked to Gaucher Disease, Parkinson Disease, and Lewy Body Dementia Alter α-Synuclein Processing |
| 000293 |
A. Q. Rana [Canada] ; J. Depradine [Canada] | Abdominal Pain: A Symptom of Levodopa End of Dose Wearing off in Parkinson's Disease |
| 000295 |
Matthias Kliegel [Allemagne] ; Mareike Altgassen [Allemagne] ; Alexandra Hering [Allemagne] ; Nathan S. Rose [Canada] | A process-model based approach to prospective memory impairment in Parkinson's disease |
| 000297 |
Moran Weinberger [Canada] ; Jonathan O. Dostrovsky [Canada] | A basis for the pathological oscillations in basal ganglia: the crucial role of dopamine |
| 000298 |
Anthony E. Lang [Canada] | A Critical Appraisal of the Premotor Symptoms of Parkinson's Disease: Potential Usefulness in Early Diagnosis and Design of Neuroprotective Trials |
| 000299 |
Christina Tremblay [Canada] ; Jessica Blais [Canada] ; Jeanne Lachance [Canada] ; Alain Ptito [Canada] ; Oury Monchi [Canada] ; Laura Monetta [Canada] | Évocation lexicale libre chez les patients atteints de la maladie de Parkinson: une analyse quantitative et qualitative des mots produits |
| 000300 |
Joseph K. Eibl [Canada] ; Zouleika Abdallah [Canada] ; Gregory M. Ross [Canada] | Zinc-metallothionein: a potential mediator of antioxidant defence mechanisms in response to dopamine-induced stress |
| 000301 |
Elena Moro [Canada] ; Clement Hamani [Canada] ; Yu-Yan Poon [Canada] ; Thamar Al-Khairallah [Canada, Arabie saoudite] ; Jonathan O. Dostrovsky [Canada] ; William D. Hutchison [Canada] ; Andres M. Lozano [Canada] | Unilateral pedunculopontine stimulation improves falls in Parkinson's disease |
| 000302 |
Tom H. Johnston [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Juha-Matti Savola [Suisse] ; Jonathan M. Brotchie [Canada] | The α2 Adrenergic Antagonist Fipamezole Improves Quality of Levodopa Action in Parkinsonian Primates |
| 000303 |
Shen-Yang Lim [Canada, Malaisie] ; Anthony E. Lang [Canada] | The Nonmotor Symptoms of Parkinson's Disease-An Overview |
| 000304 |
Sandra E. Leh [Canada] ; Michael Petrides [Canada] ; Antonio P. Strafella [Canada] | The Neural Circuitry of Executive Functions in Healthy Subjects and Parkinson's Disease |
| 000306 |
Carlo Colosimo [Italie] ; Pablo Martinez-Martin [Espagne] ; Giovanni Fabbrini [Italie] ; Robert A. Hauser [États-Unis] ; Marcelo Merello [Argentine] ; Janis Miyasaki [Canada] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Olivier Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Anette Schrag [Royaume-Uni] ; Christopher G. Goetz [États-Unis] | Task Force Report on Scales to Assess Dyskinesia in Parkinson's Disease: Critique and Recommendations |
| 000307 |
Martin Parent [Canada] ; André Parent [Canada] | Substantia Nigra and Parkinson's Disease: A Brief History of Their Long and Intimate Relationship |
| 000308 |
Marc Morissette [Canada] ; Pershia Samadi [Canada] ; ABDALLAH HADJ TAHAR [Canada] ; Nancy Belanger [Canada] ; Thérèse Di Paolo [Canada] | Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys |
| 000309 |
Jerrold L. Vitek [États-Unis] ; Kelly E. Lyons [États-Unis] ; Roy Bakay [États-Unis] ; Alim-Louis Benabid [France] ; Guenther Deuschl [Allemagne] ; Mark Hallett [États-Unis] ; Roger Kurlan [États-Unis] ; Joseph J. Pancrazio [États-Unis] ; Ali Rezai [États-Unis] ; Benjamin L. Walter [États-Unis] ; Anthony E. Lang [Canada] | Standard Guidelines for Publication of Deep Brain Stimulation Studies in Parkinson's Disease (Guide4DBS-PD) |
| 000310 |
I-Jin Yeh [Canada, Taïwan] ; Eric W. Tsang [Canada] ; Clement Hamani [Canada] ; Elena Moro [Canada] ; Filomena Mazzella [Canada] ; Yu-Yan Poon [Canada] ; Andres M. Lozano [Canada] ; Robert Chen [Canada] | Somatosensory Evoked Potentials Recorded from the Human Pedunculopontine Nucleus Region |
| 000311 |
Lisa M. Lix [Canada] ; Douglas E. Hobson [Canada] ; Mahmoud Azimaee [Canada] ; William D. Leslie [Canada] ; Charles Burchill [Canada] ; Shaun Hobson [Canada] | Socioeconomic variations in the prevalence and incidence of Parkinson's disease: a population-based analysis |
| 000312 |
R. B. Postuma [Canada] ; J. F. Gagnon [Canada] ; S. Rompre [Canada] ; J. Y. Montplaisir [Canada] | Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease |
| 000313 |
Benedicte Ballanger [États-Unis] ; Antonio P. Strafella [États-Unis, Canada] ; Thilo Van Eimeren [États-Unis] ; Mateusz Zurowski [États-Unis] ; Pablo M. Rusjan [États-Unis] ; Sylvain Houle [États-Unis] ; Susan H. Fox [États-Unis] | Serotonin 2A Receptors and Visual Hallucinations in Parkinson Disease |
| 000314 |
Michael S. Okun [États-Unis] ; Anthony Lang [Canada] ; Joseph Jankovic [États-Unis] | Reply: Based on the Available Randomized Trial Patients Should Say No to Glutathione for Parkinson's Disease |
| 000315 |
K. A. Links [Canada] ; D. Merims [Canada] ; M. A. Binns [Canada] ; M. Freedman [Canada] ; T. W. Chow [Canada] | Prevalence of Primitive Reflexes and Parkinsonian Signs in Dementia |
| 000316 |
Robert A. Hodgson [États-Unis] ; Paul J. Bedard [Canada] ; Geoffrey B. Varty [États-Unis] ; Tatiana M. Kazdoba [États-Unis] ; Therese Di Paolo [Canada] ; Michael E. Grzelak [États-Unis] ; Annamarie J. Pond [États-Unis] ; Abdallah Hadjtahar [Canada] ; Nancy Belanger [Canada] ; Laurent Gregoire [Canada] ; Aurelie Dare [Canada] ; Bernard R. Neustadt [États-Unis] ; Andrew W. Stamford [États-Unis] ; John C. Hunter [États-Unis] | Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders |
| 000317 |
T. A. Zesiewicz [États-Unis] ; K. L. Sullivan [États-Unis] ; I. Arnulf [France] ; K. R. Chaudhuri [Royaume-Uni] ; J. C. Morgan [États-Unis] ; G. S. Gronseth [États-Unis] ; J. Miyasaki [Canada] ; D. J. Iverson [États-Unis] ; W. J. Weiner [États-Unis] | Practice Parameter: Treatment of nonmotor symptoms of Parkinson disease: Report of the Quality Standards Subcommittee of the American Academy of Neurology |
| 000318 |
S. W. Hung [Canada, États-Unis] ; G. M. Adeli [Canada] ; T. Arenovich [Canada] ; S. H. Fox [Canada] ; A. E. Lang [Canada] | Patient perception of dyskinesia in Parkinson's disease |
| 000319 |
A. Bharmal [Canada] ; C. Lu [Canada] ; J. Quickfall [Canada] ; D. Crockford [Canada] ; O. Suchowersky [Canada] | Outcomes of Patients with Parkinson Disease and Pathological Gambling |
| 000321 |
Susan H. Fox [Canada] ; Naomi Visanji [Canada] ; Gaby Reyes [Canada] ; Philippe Huot [Canada] ; Jordi Gomez-Ramirez [Canada] ; Tom Johnston [Canada] ; Jonathan M. Brotchie [Canada] | Neuropsychiatric Behaviors in the MPTP Marmoset Model of Parkinson's Disease |
| 000322 |
Pierre-Luc Tremblay [Canada] ; Marc-Andre Bedard [Canada] ; Dominic Langlois [Canada] ; Pierre J. Blanchet [Canada] ; Martin Lemay [Canada] ; Maxime Parent [Canada] | Movement chunking during sequence learning is a dopamine-dependant process: a study conducted in Parkinson's disease |
| 000324 |
M. Barnett-Cowan [Canada] ; R. T. Dyde [Canada] ; S. H. Fox [Canada] ; E. Moro [Canada] ; W. D. Hutchison [Canada] ; L. R. Harris [Canada] | MULTISENSORY DETERMINANTS OF ORIENTATION PERCEPTION IN PARKINSON'S DISEASE |
| 000325 |
I. Irrcher [Canada] ; H. Aleyasin [Canada] ; E. L. Seifert [Canada] ; S. J. Hewitt [Canada] ; S. Chhabra [Canada] ; M. Phillips [Canada] ; A. K. Lutz [Allemagne] ; M. W. C. Rousseaux [Canada] ; L. Bevilacqua [Canada] ; A. Jahani-Asl [Canada] ; S. Callaghan [Canada] ; J. G. Maclaurin [Canada] ; K. F. Winklhofer [Allemagne] ; P. Rizzu [Pays-Bas] ; P. Rippstein [Canada] ; R. H. Kim [Canada] ; C. X. Chen [Canada] ; E. A. Fon [Canada] ; R. S. Slack [Canada] ; M. E. Harper [Canada] ; H. M. Mcbride [Canada] ; T. W. Mak [Canada] ; D. S. Park [Canada, Corée du Sud] | Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics |
| 000326 |
Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Pierre Pollak [France] ; Yves Agid [France] ; Stig Rehncrona [Suède] ; Jens Volkmann [Allemagne] ; Jaime Kulisevsky [Espagne] ; Jose A. Obeso [Espagne] ; Alberto Albanese [Italie] ; Marwan I. Hariz [Royaume-Uni, Suède] ; Niall P. Quinn [Canada] ; Jans D. Speelman [Pays-Bas] ; Alim L. Benabid [France] ; Valerie Fraix [France] ; Alexandre Mendes [France] ; Marie-Laure Welter [France] ; Jean-Luc Houeto [France] ; Philippe Cornu [France] ; Didier Dormont [France] ; Annalena L. Tornqvist [Suède] ; Ron Ekberg [Suède] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Lars Wojtecki [Allemagne] ; Andres Gironell [Espagne] ; Maria C. Rodriguez-Oroz [Espagne] ; Jorge Guridi [Espagne] ; Anna R. Bentivoglio [Italie] ; Maria F. Contarino [Italie, Pays-Bas] ; Luigi Romito [Italie] ; Massimo Scerrati [Italie] ; Marc Janssens [Pays-Bas] ; Anthony E. Lang [Canada] | Long-Term Results of a Multicenter Study on Subthalamic and Pallidal Stimulation in Parkinson's Disease |
| 000327 |
Galit Kleiner-Fisman [Canada] ; Andres Lozano [Canada] ; Elena Moro [Canada] ; Yu-Yan Poon [Canada] ; Anthony E. Lang [Canada] | Long-Term Effect of Unilateral Pallidotomy on Levodopa-Induced Dyskinesia |
| 000328 |
Cory Toth [Canada] ; Kim Breithaupt [Canada] ; SHAOHUA GE [Canada] ; YANJUN DUAN [Canada] ; Joan M. Terris [Canada] ; Anita Thiessen [Canada] ; Samuel Wiebe [Canada] ; Douglas W. Zochodne [Canada] ; Oksana Suchowersky [Canada] | Levodopa, Methylmalonic Acid, and Neuropathy in Idiopathic Parkinson Disease |
| 000331 |
Connie Marras [Canada] ; Christine Klein [Canada, Allemagne] ; Anthony E. Lang [Canada] ; Yosuke Wakutani [Canada] ; Danielle Moreno [Canada] ; Christine Sato [Canada] ; Edwin Yip [Canada] ; Renato P. Munhoz [Brésil] ; Katja Lohmann [Allemagne] ; Ana Dj Armati [Allemagne] ; Andrew Bi [Canada] ; Ekaterina Rogaeva [Canada] | LRRK2 and Parkin mutations in a family with parkinsonism-Lack of genotype-phenotype correlation |
| 000332 |
Carles Vilarino-Güell [États-Unis] ; Christian Wider [Suisse] ; Owen A. Ross [États-Unis] ; Barbara Jasinska-Myga [Pologne] ; Jennifer Kachergus [États-Unis] ; Stephanie A. Cobb [États-Unis] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Bahareh Behrouz [États-Unis] ; Michael G. Heckman [États-Unis] ; Nancy N. Diehl [États-Unis] ; Claudia M. Testa [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; Ryan J. Uitti [États-Unis] ; Joseph Jankovic [États-Unis] ; Elan D. Louis [États-Unis] ; Lorraine N. Clark [États-Unis] ; Alex Rajput [Canada] ; Matthew J. Farrer [États-Unis] | LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease |
| 000333 |
Wing-Lok Au [Singapour] ; NI LEI [Canada] ; Meeko M. K. Oishi [Canada] ; Martin J. Mckeown [Canada] | L-Dopa induces under-damped visually guided motor responses in Parkinson's disease |
| 000334 |
S. J. Palmer [Canada] ; J. Li [Canada] ; Z. J. Wang [Canada] ; M. J. Mckeown [Canada] | JOINT AMPLITUDE AND CONNECTIVITY COMPENSATORY MECHANISMS IN PARKINSON'S DISEASE |
| 000336 |
ZHEN NI [Canada] ; Andrew D. Pinto [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada] | Involvement of the Cerebellothalamocortical Pathway in Parkinson Disease |
| 000337 |
Estifanos Ghebremedhin [Allemagne, Australie] ; Albert Rosenberger [Allemagne] ; Udo Rüb [Allemagne] ; Mario Vuksic [Croatie] ; Tzeggai Berhe [Canada] ; Heike Bickeböller [Allemagne] ; Rob A. I. De Vos [Pays-Bas] ; Dietmar R. Thal [Allemagne] ; Thomas Deller [Allemagne] | Inverse Relationship Between Cerebrovascular Lesions and Severity of Lewy Body Pathology in Patients With Lewy Body Diseases |
| 000338 |
Rena K. Mann [Canada] ; Roderick Edwards [Canada] ; Julie Zhou [Canada] ; Mandar Jog [Canada] ; Christian Duval [Canada] | Intra- and inter-limb coherency during stance in non-dyskinetic and dyskinetic patients with Parkinson's disease |
| 000339 |
Tiffiny Chan [Canada] ; Arim. Chow [Canada] ; Derekw. F. Tang [Canada] ; QI LI [Canada] ; XUANYUANWANG [Canada] ; Ian R. Brown [Canada] ; Kagan Kerman [Canada] | Interaction of baicalein and copper with α-synuclein: Electrochemical approach to Parkinson's Disease |
| 000340 |
Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Karl Kieburtz [États-Unis] ; Werner Poewe [Autriche] ; Joseph Jankovic [États-Unis] ; Eduardo Tolosa [Espagne] ; Paulo Barone [Italie] ; Anthony E. Lang [Canada] ; C. Warren Olanow [États-Unis] | Initiating Levodopa/Carbidopa Therapy With and Without Entacapone in Early Parkinson Disease: The STRIDE-PD Study |
| 000341 |
John M. Bertoni [États-Unis] ; John Philip Arlette [Canada] ; Hubert H. Fernandez [États-Unis] ; Cheryl Fitzer-Attas [Israël] ; Karen Frei [États-Unis] ; Mohamed N. Hassan [États-Unis] ; Stuart H. Isaacson [États-Unis] ; Mark F. Lew [États-Unis] ; Eric Molho [États-Unis] ; William G. Ondo [États-Unis] ; Tania J. Phillips [États-Unis] ; Carlos Singer [États-Unis] ; James P. Sutton [États-Unis] ; John E. Jr Wolf [États-Unis] | Increased Melanoma Risk in Parkinson Disease: A Prospective Clinicopathological Study |
| 000342 |
Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Tayyeba Darr [Canada] ; Lili-Naz Hazrati [Canada] ; Naomi P. Visanji [Canada] ; Donna Pires [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada] | Increased 5-HT2A Receptors in the Temporal Cortex of Parkinsonian Patients with Visual Hallucinations |
| 000343 |
Russell C. Callaghan [Canada] ; James K. Cunningham [États-Unis] ; Gautam Sajeev [Canada] ; Stephen J. Kish [Canada] | Incidence of Parkinson's Disease Among Hospital Patients with Methamphetamine-Use Disorders |
| 000344 |
Daniel Weintraub [États-Unis] ; Juergen Koester [Allemagne] ; Marc N. Potenza [États-Unis] ; Andrew D. Siderowf [États-Unis] ; Mark Stacy [États-Unis] ; Valerie Voon [Canada] ; Jacqueline Whetteckey [États-Unis] ; Glen R. Wunderlich [Canada] ; Anthony E. Lang [Canada] | Impulse Control Disorders in Parkinson Disease: A Cross-Sectional Study of 3090 Patients |
| 000345 |
Rodger J. Elble [États-Unis] ; Oksana Suchowersky [Canada] ; Stephanie Shaftman [Canada, États-Unis] ; William J. Weiner [États-Unis] ; PENG HUANG [États-Unis] ; Barbara Tilley [États-Unis] | Impact of Belief in Neuroprotection on Therapeutic Intervention in Parkinson's Disease |
| 000346 |
JUN LIU [République populaire de Chine, États-Unis] ; MIN SHI [États-Unis] ; ZHEN HONG [République populaire de Chine] ; JIANPENG ZHANG [États-Unis] ; Joshua Bradner [États-Unis] ; Thomas Quinn [États-Unis] ; Richard P. Beyer [États-Unis] ; Patrick L. Mcgeer [Canada] ; SHENGDI CHEN [République populaire de Chine] ; JING ZHANG [États-Unis] | Identification of ciliary neurotrophic factor receptor α as a mediator of neurotoxicity induced by α-synuclein |
| 000347 |
Myriam Lafreniere-Roula [Canada] ; Elaine Kim [Canada] ; William D. Hutchison [Canada] ; Andres M. Lozano [Canada] ; Mojgan Hodaie [Canada] ; Jonathan O. Dostrovsky [Canada] | High-frequency microstimulation in human globus pallidus and substantia nigra |
| 000349 |
Renan P. Souza [Canada] ; Vincenzo De Luca [Canada] ; Gary Remington [Canada] ; Jeffrey A. Lieberman [États-Unis] ; Herbert Y. Meltzer [États-Unis] ; James L. Kennedy [Canada] ; Albert H. C. Wong [Canada] | Glial cell line-derived neurotrophic factor receptor alpha 2 (GFRA2) gene is associated with tardive dyskinesia |
| 000352 |
Q. J. Almeida [Canada] ; C. A. Lebold [Canada] | Freezing of gait in Parkinson's disease: a perceptual cause for a motor impairment? |
| 000353 |
Bernard Ng [Canada] ; Samantha Palmer [Canada] ; Rafeef Abugharbieh [Canada] ; Martin J. Mckeown [Canada] | Focusing Effects of L-Dopa in Parkinson's Disease |
| 000354 |
RUKSANA AZHU VALAPPIL [États-Unis] ; Jed E. Black [États-Unis] ; Meredith J. Broderick [États-Unis] ; Oscar Carrillo [États-Unis] ; Eric Frenette [Canada] ; Shannon S. Sullivan [États-Unis] ; Samuel M. Goldman [États-Unis] ; Caroline M. Tanner [États-Unis] ; James W. Langston [États-Unis] | Exploring the Electrocardiogram as a Potential Tool to Screen for Premotor Parkinson's Disease |
| 000355 |
Ian G. M. Cameron [Canada] ; Masayuki Watanabe [Canada] ; Giovanna Pari [Canada] ; Douglas P. Munoz [Canada] | Executive impairment in Parkinson's disease: Response automaticity and task switching |
| 000356 |
Janis M. Miyasaki [Canada] | Evidence-based initiation of dopaminergic therapy in Parkinson's disease |
| 000357 |
Ron Levy [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] ; Jonathan O. Dostrovsky [Canada] | Event-related desynchronization of motor cortical oscillations in patients with multiple system atrophy |
| 000358 |
QINGJIA MENG [Canada] ; Dirk W. Luchtman [Canada] ; BOUCHAIB EL BAHH [Canada] ; Jeffrey A. Zidichouski [Canada] ; JUN YANG [Canada] ; CAI SONG [Canada] | Ethyl-eicosapentaenoate modulates changes in neurochemistry and brain lipids induced by parkinsonian neurotoxin 1-methyl-4-phenylpyridinium in mouse brain slices |
| 000359 |
Henri Cohen [France, Canada] ; Marie-Hélène Gagne [Canada] ; Ursula Hess [Canada] ; Emmanuelle Pourcher [France, Canada] | Emotion and object processing in Parkinson's disease |
| 000360 |
Sarah C. Lidstone [Canada] ; Michael Schulzer [Canada] ; Katherine Dinelle [Canada] ; Edwin Mak [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Anthony G. Phillips [Canada] ; A. Jon Stoessl [Canada] | Effects of Expectation on Placebo-Induced Dopamine Release in Parkinson Disease |
| 000361 |
Bazoumana Ouattara [Canada] ; Fabrizio Gasparini [Suisse] ; Marc Morissette [Canada] ; Laurent Gregoire [Canada] ; Pershia Samadi [Canada] ; Baltazar Gomez-Mancilla [Suisse] ; Thérèse Di Paolo [Canada] | Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys |
| 000362 |
Tom H. Johnston [Canada] ; Anne Van Der Meij [Pays-Bas] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada] | Effect of Histamine H2 Receptor Antagonism on Levodopa-Induced Dyskinesia in the MPTP-Macaque Model of Parkinson's Disease |
| 000363 |
Alberto J. Espay [États-Unis] ; Jennifer E. Vaughan [États-Unis] ; Connie Marras [Canada] ; Rob Fowler [Canada] ; Mark H. Eckman [États-Unis] | Early Versus Delayed Bilateral Subthalamic Deep Brain Stimulation for Parkinson's Disease: A Decision Analysis |
| 000364 |
Silke Paulmann [Canada, Royaume-Uni] ; Marc D. Pell [Canada] | Dynamic emotion processing in Parkinson's disease as a function of channel availability |
| 000366 |
Juliana Bronzova [Pays-Bas] ; Cristina Sampaio [Portugal] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Ad Theeuwes [Pays-Bas] ; Serge V. Van De Witte [Pays-Bas] ; Guus Van Scharrenburg [Pays-Bas] | Double-Blind Study of Pardoprunox, a New Partial Dopamine Agonist, in Early Parkinson's Disease |
| 000367 |
Melanie Cohn [Canada] ; Morris Moscovitch [Canada] ; Patrick S. R. Davidson [Canada] | Double dissociation between familiarity and recollection in Parkinson's disease as a function of encoding tasks |
| 000368 |
Vesna Sossi [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Ramachandiran Nandhagopal [Canada] ; Michael Schulzer [Canada] ; Jessamyn Mckenzie [Canada] ; Thomas J. Ruth [Canada] ; Jan O. Aasly [Norvège] ; Matthew J. Farrer [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; Jon A. Stoessl [Canada] | Dopamine Turnover Increases in Asymptomatic LRRK2 Mutations Carriers |
| 000371 |
Zang-Hee Cho [Corée du Sud, États-Unis] ; Hoon-Ki Min [Corée du Sud, États-Unis] ; Se-Hong Oh [Corée du Sud] ; Jae-Yong Han [Corée du Sud] ; Chan-Woong Park [Corée du Sud] ; Je-Geun Chi [Corée du Sud] ; Young-Bo Kim [Corée du Sud] ; SUN HA PAEK [Corée du Sud] ; Andres M. Lozano [Canada] ; Kendall H. Lee [États-Unis] | Direct visualization of deep brain stimulation targets in Parkinson disease with the use of 7-tesla magnetic resonance imaging: Clinical article |
| 000372 |
Andres M. Lozano [Canada] ; Philip A. Starr [États-Unis] ; Alastair J. Martin [États-Unis] ; Jill L. Ostrem [États-Unis] ; Nadja Levesque [États-Unis] ; Pekka Talke [États-Unis] ; Paul S. Larson [États-Unis] | Deep brain stimulation for Parkinson disease |
| 000375 |
C. Gibrat [Canada] ; M. Bousquet [Canada] ; M. Saint-Pierre [Canada] ; D. Levesque [Canada] ; F. Calon [Canada] ; C. Rouillard [Canada] ; F. Cicchetti [Canada] | Cystamine prevents MPTP-induced toxicity in young adult mice via the up-regulation of the brain-derived neurotrophic factor |
| 000376 |
Mélanie Bousquet [Canada] ; Claire Gibrat [Canada] ; Mélissa Ouellet [Canada] ; Claude Rouillard [Canada] ; Frédéric Calon [Canada] ; Francesca Cicchetti [Canada] | Cystamine metabolism and brain transport properties: clinical implications for neurodegenerative diseases |
| 000377 |
Katie Wiltshire [Canada] ; Luis Concha [Canada] ; Myrlene Gee [Canada] ; Thomas Bouchard [Canada] ; Christian Beaulieu [Canada] ; Richard Camicioli [Canada] | Corpus Callosum and Cingulum Tractography in Parkinson's Disease |
| 000379 |
Andrew H. Evans [Australie, Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Silke Appel Cresswell [Canada] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew J. Lees [Royaume-Uni] | Compulsive Use of Dopaminergic Drug Therapy in Parkinson's Disease: Reward and Anti-Reward |
| 000380 |
R. B. Postuma [Canada] ; J. F. Gagnon [Canada] ; J. Montplaisir [Canada] | Clinical prediction of Parkinson's disease: planning for the age of neuroprotection |
| 000381 |
Jon B. Doan [Canada] ; Ian Q. Whishaw [Canada] ; Sergio M. Pellis [Canada] ; Oksana Suchowersky [Canada] ; Natalie De Bruin [Canada] ; Lesleya. Brown [Canada] | Challenging context affects standing reach kinematics among Parkinson's disease patients |
| 000382 |
Ronald B. Postuma [Canada] ; Paola A. Lanfranchi [Canada] ; Helene Blais [Canada] ; Jean-Francois Gagnon [Canada] ; Jacques Y. Montplaisir | Cardiac Autonomic Dysfunction in Idiopathic REM Sleep Behavior Disorder |
| 000383 |
B. Xu [Canada] ; J. S. Goldman [Canada] ; V. V. Rymar [Canada] ; C. Forget [Canada] ; P. S. Lo [Canada] ; S. J. Bull [Canada] ; E. Vereker [Canada] ; P. A. Barker [Canada] ; L. E. Trudeau [Canada] ; A. F. Sadikot [Canada] ; T. E. Kennedy [Canada] | CRITICAL ROLES FOR THE NETRIN RECEPTOR DELETED IN COLORECTAL CANCER IN DOPAMINERGIC NEURONAL PRECURSOR MIGRATION, AXON GUIDANCE, AND AXON ARBORIZATION |
| 000384 |
B. Ouattara [Canada] ; D. Hoyer [Suisse] ; L. Gregoire [Canada] ; M. Morissette [Canada] ; F. Gasparini [Suisse] ; B. Gomez-Mancilla [Suisse] ; T. Di Paolo [Canada] | CHANGES OF AMPA RECEPTORS IN MPTP MONKEYS WITH LEVODOPA-INDUCED DYSKINESIAS |
| 000385 |
JUNCHAO TONG [Canada] ; Henry Wong [Canada] ; Mark Guttman [Canada] ; Lee C. Ang [Canada] ; Lysia S. Forno [États-Unis] ; Mitsunobu Shimadzu [Japon] ; Ali H. Rajput [Canada] ; Manfred D. Muenter [États-Unis] ; Stephen J. Kish [Canada] ; Oleh Hornykiewicz [Autriche] ; Yoshiaki Furukawa [Canada, Japon] | Brain α-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation |
| 000389 |
Andres M. Lozano [Canada] ; Brian J. Snyder [Canada] ; Clement Hamani [Canada] ; William D. Hutchison [Canada] ; Jonathan O. Dostrovsky [Canada] | Basal Ganglia Physiology and Deep Brain Stimulation |
| 000390 |
Cathy Lu [Canada] ; Aamir Bharmal [Canada] ; Zelma H. Kiss [Canada] ; Oksana Suchowersky [Canada] ; Angela M. Haffenden [Canada] | Attention and reach-to-grasp movements in Parkinson's disease |
| 000392 |
M. Lafreniere-Roula [Canada] ; O. Darbin [États-Unis] ; W. D. Hutchison [Canada] ; T. Wichmann [États-Unis] ; A. M. Lozano [Canada] ; J. O. Dostrovsky [Canada] | Apomorphine reduces subthalamic neuronal entropy in parkinsonian patients |
| 000393 |
André Bonnici [Canada] ; Carola-Ellen Ruiner [Canada] ; Lyne St-Laurent [Canada] ; David Hornstein [Canada] | An Interaction Between Levodopa and Enteral Nutrition Resulting in Neuroleptic Malignant-Like Syndrome and Prolonged ICU Stay |
| 000394 |
Kaitlyn P. Roland [Canada] ; Mary E. Jenkins [Canada] ; Andrew M. Johnson [Canada] | An Exploration of the Burden Experienced by Spousal Caregivers of Individuals with Parkinson's Disease |
| 000395 |
Daniel Weintraub [États-Unis] ; Mandy Sohr [Allemagne] ; Marc N. Potenza [États-Unis] ; Andrew D. Siderowf [États-Unis] ; Mark Stacy [États-Unis] ; Valerie Voon [Royaume-Uni] ; Jacqueline Whetteckey [États-Unis] ; Glen R. Wunderlich [Canada] ; Anthony E. Lang [Canada] | Amantadine Use Associated with Impulse Control Disorders in Parkinson Disease in Cross-Sectional Study |
| 000396 |
Emmanuelle Pourcher [Canada, France] ; Sophie Remillard [Canada] ; Henri Cohen [Canada, France] | Affect in Parkinson's disease: validation of the two-factor approach |
| 000398 |
Andrew R. Brown [Canada] ; BIN HU [Canada] ; Bryan Kolb [Canada] ; G. Campbell Teskey [Canada] | Acoustic tone or medial geniculate stimulation cue training in the rat is associated with neocortical neuroplasticity and reduced akinesia under haloperidol challenge |
| 000399 |
Kelvin L. Chou [États-Unis] ; Melissa M. Amick [États-Unis] ; Jason Brandt [États-Unis] ; Richard Camicioli [Canada] ; Karen Frei [États-Unis] ; Darren Gitelman [États-Unis] ; Jennifer Goldman [États-Unis] ; John Growdon [États-Unis] ; Howard I. Hurtig [États-Unis] ; Bonnie Levin [États-Unis] ; Irene Litvan [États-Unis] ; Laura Marsh [États-Unis] ; Tanya Simuni [États-Unis] ; Alexander I. Tröster [États-Unis] ; Ergun Y. Uc [États-Unis] | A Recommended Scale for Cognitive Screening in Clinical Trials of Parkinson's Disease |
| 000400 |
Michael D. Sage [Canada] ; Quincy J. Almeida [Canada] | A Positive Influence of Vision on Motor Symptoms During Sensory Attention Focused Exercise for Parkinson's Disease |
| 000401 |
P.-J. Blanchet [Canada] ; B. Lalonde [Canada] ; G.-J. Lavigne [Canada] | Douleur orofaciale et désordres oromoteurs |
| 000402 |
Anthony E. Lang [Canada] | When and how should treatment be started in Parkinson disease? |
| 000403 |
Alexander Klein [Canada, Allemagne] ; Johanna Wessolleck [Allemagne] ; Anna Papazoglou [Allemagne] ; Gerlinde A. Metz [Canada] ; Guido Nikkhah [Allemagne] | Walking pattern analysis after unilateral 6-OHDA lesion and transplantation of foetal dopaminergic progenitor cells in rats |
| 000404 |
Desirae M. Haluk [Canada] ; Stan B. Floresco [Canada] | Ventral Striatal Dopamine Modulation of Different Forms of Behavioral Flexibility |
| 000405 |
Daniel Weintraub [États-Unis] ; Staci Hoops [États-Unis] ; Judy A. Shea [États-Unis] ; Kelly E. Lyons [États-Unis] ; Rajesh Pahwa [États-Unis] ; Erika D. Driver-Dunckley [États-Unis] ; Charles H. Adler [États-Unis] ; Marc N. Potenza [États-Unis] ; Janis Miyasaki [Canada] ; Andrew D. Siderowf [États-Unis] ; John E. Duda [États-Unis] ; Howard I. Hurtig [États-Unis] ; Amy Colcher [États-Unis] ; Stacy S. Horn [États-Unis] ; Matthew B. Stern [États-Unis] ; Valerie Voon [États-Unis] | Validation of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease |
| 000406 |
Alberto Ascherio [États-Unis] ; Peter A. Lewitt [États-Unis] ; KUI XU [États-Unis] ; Shirley Eberly [États-Unis] ; Arthur Watts [États-Unis] ; Wayne R. Matson [États-Unis] ; Connie Marras [Canada] ; Karl Kieburtz [États-Unis] ; Alice Rudolph [États-Unis] ; Mikhail B. Bogdanov [États-Unis] ; Steven R. Schwid [États-Unis] ; Marsha Tennis [États-Unis] ; Caroline M. Tanner [États-Unis] ; M. Flint Beal [États-Unis] ; Anthony E. Lang [Canada] ; David Oakes [États-Unis] ; Stanley Fahn [États-Unis] ; Ira Shoulson [États-Unis] ; Michael A. Schwarzschild [États-Unis] | Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease |
| 000408 |
Elan D. Louis [États-Unis] ; Phyllis L. Faust [États-Unis] ; Jean-Paul G. Vonsattel [États-Unis] ; Lawrence S. Honig [États-Unis] ; Alex Rajput [Canada] ; Ali Rajput [Canada] ; Rajesh Pahwa [États-Unis] ; Kelly E. Lyons [États-Unis] ; Webster G. Ross [États-Unis] ; Rodger J. Elble [États-Unis] ; Cordelia Erickson-Davis [États-Unis] ; Carol B. Moskowitz [États-Unis] ; Arlene Lawton [États-Unis] | Torpedoes in Parkinson's Disease, Alzheimer's Disease, Essential Tremor, and Control Brains |
| 000409 |
Grace Lee [Canada] ; Tony Chu [Canada] ; Christopher A. Shaw [Canada] | The primary locus of motor neuron death in an ALS-PDC mouse model |
| 000411 |
WEI SONG [Canada] ; Amar Patel [Canada] ; Hamid Y. Qureshi [Canada] ; DONG HAN [Canada] ; Hyman M. Schipper [Canada] ; Hemant K. Paudel [Canada] | The Parkinson disease-associated A30P mutation stabilizes α-synuclein against proteasomal degradation triggered by heme oxygenase-1 over-expression in human neuroblastoma cells |
| 000412 |
Bernard Ravina [États-Unis] ; Jordan Elm [États-Unis] ; Richard Camicioli [Canada] ; Peter G. Como [États-Unis] ; Laura Marsh [États-Unis] ; Joseph Jankovic [États-Unis] ; Daniel Weintraub [États-Unis] | The Course of Depressive Symptoms in Early Parkinson's Disease |
| 000413 |
Christina Zaleski [États-Unis] ; Anne S. Bassett [Canada] ; Karen Tam [Canada] ; Andrea L. Shugar [Canada] ; Eva W. C. Chow [Canada] ; Elizabeth Mcpherson [États-Unis] | The Co-Occurrence of Early Onset Parkinson Disease and 22q11.2 Deletion Syndrome |
| 000414 |
W. R. Wayne Martin [Canada] ; Marguerite Wieler [Canada] ; Myrlene Gee [Canada] ; Richard Camicioli [Canada] | Temporal Lobe Changes in Early, Untreated Parkinson's Disease |
| 000416 |
Michael D. Sage [Canada] ; Quincy J. Almeida [Canada] | Symptom and Gait Changes After Sensory Attention Focused Exercise vs Aerobic Training in Parkinson's Disease |
| 000418 |
Susan H. Fox [Canada] ; Rosalind Chuang [Canada] ; Jonathan M. Brotchie [Canada] | Serotonin and Parkinson's Disease: On Movement, Mood, and Madness |
| 000420 |
Emily Bell [Canada] ; Ghislaine Mathieu [Canada] ; Eric Racine [Canada] ; Konstantin V. Slavin [États-Unis] | Preparing the ethical future of deep brain stimulation. Commentary |
| 000424 |
Christian Wider [États-Unis] ; Sarah J. Lincoln [États-Unis] ; Michael G. Heckman [États-Unis] ; Nancy N. Diehl [États-Unis] ; Jeremy T. Stone [États-Unis] ; Kristoffer Haugarvoll [États-Unis, Norvège] ; Jan O. Aasly [Norvège] ; J. Mark Gibson [Irlande (pays)] ; Timothy Lynch [Irlande (pays)] ; Alex Rajput [Canada] ; Michele L. Rajput [Canada] ; Ryan J. Uitti [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; Matthew J. Farrer [États-Unis] ; Owen A. Ross [États-Unis] | Phactr2 and Parkinson's disease |
| 000427 |
Shen-Yang Lim [Canada] ; Susan H. Fox [Canada] ; Anthony E. Lang [Canada] | Overview of the Extranigral Aspects of Parkinson Disease |
| 000428 |
Lesley A. Brown [Canada] ; Natalie De Bruin [Canada] ; Jon B. Doan [Canada] ; Oksana Suchowersky [Canada] ; BIN HU [Canada] | Novel Challenges to Gait in Parkinson's Disease: The Effect of Concurrent Music in Single- and Dual-Task Contexts |
| 000430 |
Andrew R. Brown [Canada] ; BIN HU [Canada] ; Michael C. Antle [Canada] ; G. Campbell Teskey [Canada] | Neocortical movement representations are reduced and reorganized following bilateral intrastriatal 6-hydroxydopamine infusion and dopamine type-2 receptor antagonism |
| 000431 |
Ali Samii [États-Unis] ; Mahyar Etminan [Canada] ; Matthew O. Wiens [Canada] ; Siavash Jafari [Canada] | NSAID Use and the Risk of Parkinson's Disease: Systematic Review and Meta-Analysis of Observational Studies |
| 000433 |
M. Bousquet [Canada] ; C. Gibrat [Canada] ; M. Saint-Pierre [Canada] ; C. Julien [Canada] ; F. Calon [Canada] ; F. Cicchetti [Canada] | Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model |
| 000434 |
Jean-Francois Gagnon [Canada] ; Mélanie Vendette [Canada] ; Ronald B. Postuma [Canada] ; Catherine Desjardins [Canada] ; Jessica Massicotte-Marquez [Canada] ; Michel Panisset [Canada] ; Jacques Montplaisir [Canada] | Mild Cognitive Impairment in Rapid Eye Movement Sleep Behavior Disorder and Parkinson's Disease |
| 000436 |
Pershia Samadi [Canada] ; Alex Rajput [Canada] ; Frédéric Calon [Canada] ; Laurent Gregoire [Canada] ; Oleh Homykiewicz [Canada, Autriche] ; Ali H. Rajput [Canada] ; Thèrèse Di Paolo [Canada] | Metabotropic Glutamate Receptor II in the Brains of Parkinsonian Patients |
| 000438 |
Jonathan Brotchie [Canada] ; Cheryl Fitzer-Attas [Israël] | Mechanisms compensating for dopamine loss in early Parkinson disease |
| 000439 |
R. B. Postuma [Canada] ; J. F. Gagnon [Canada] ; M. Vendette [Canada] ; J. Y. Montplaisir [Canada] | Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease |
| 000440 |
Bart F. L. Van Nuenen [Pays-Bas, Allemagne] ; Thilo Van Eimeren [Canada] ; Joyce P. M. Van Der Vegt [Pays-Bas, Allemagne] ; Carsten Buhmann [Allemagne] ; Christine Klein [Allemagne] ; Bastiaan R. Bloem [Pays-Bas] ; Hartwig R. Siebner [Allemagne, Danemark] | Mapping Preclinical Compensation in Parkinson's Disease: An Imaging Genomics Approach |
| 000441 |
C. Allyson Jones [Canada] ; Sheri L. Pohar [Canada] ; Scott B. Patten [Canada] | Major depression and health-related quality of life in Parkinson's disease |
| 000442 |
Volker A. Coenen [Canada, Allemagne] ; Christopher R. Honey [Canada] ; Trevor Hurwitz [Allemagne] ; Ahmed A. Rahman [Canada] ; Jacqueline Mcmaster [Canada] ; Uli Bürgel [Allemagne] ; Burkhard M Dler [Pays-Bas] ; Robert E. Gross ; Philip A. Starr ; Clement Hamani ; Andres M. Lozano ; Robert R. Goodman | MEDIAL FOREBRAIN BUNDLE STIMULATION AS A PATHOPHYSIOLOGICAL MECHANISM FOR HYPOMANIA IN SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION FOR PARKINSON'S DISEASE |
| 000443 |
R. Nandhagopal [Canada] ; L. Kuramoto [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; J. Cragg [Canada] ; Chong S. Lee [Canada] ; J. Mckenzie [Canada] ; S. Mccormick [Canada] ; A. Samii [États-Unis] ; A. Troiano [Canada] ; T. J. Ruth [Canada] ; V. Sossi [Canada] ; R. De La Fuente-Fernandez [Canada] ; Donald B. Caine [Canada] ; A. J. Stoessl [Canada] | Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study |
| 000444 |
Jens Volkmann [Allemagne] ; Alberto Albanese [Italie] ; Jaime Kulisevsky [Espagne] ; Aana-Lena Tornqvist [Suède] ; Jean-Luc Houeto [France] ; Bernard Pidoux [France] ; Anne-Marie Bonnet [France] ; Alexandre Mendes [France] ; Alim-Louis Benabid [France] ; Valerie Fraix [France] ; Nadege Van Blercom [France] ; JING XIE [France] ; José Obeso [Espagne] ; Maria Cruz Rodriguez-Oroz [Espagne] ; Jurge Guridi [Espagne] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Alexandre A. Gironell [Espagne] ; Juan Molet [Espagne] ; Benta Pascual-Sedano [Espagne] ; Stig Rehncrona [Suède] ; Elena Moro [Canada] ; Anthony C. Lang [Canada] ; Andres M. Lozano [Canada] ; Anna Rita Bentivoglio [Italie] ; Massimo Scerrati [Italie] ; Maria Fiorella Contarino [Pays-Bas] ; Luigi Romito [Italie] ; Marc Janssens [Pays-Bas] ; Yves Agid [France] | Long-Term Effects of Pallidal or Subthalamic Deep Brain Stimulation on Quality of Life in Parkinson's Disease |
| 000446 |
I. A. Prescott [Canada] ; J. O. Dostrovsky [Canada] ; E. Moro [Canada] ; M. Hodaie [Canada] ; A. M. Lozano [Canada] ; W. D. Hutchison [Canada] | Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients |
| 000447 |
Katerina Venderova [Canada] ; Ghassan Kabbach [Canada] ; Elizabeth Abdel-Messih [Canada] ; YI ZHANG [Canada] ; Robin J. Parks [Canada] ; Yuzuru Imai [Japon] ; Stephan Gehrke [États-Unis] ; Johnny Ngsee [Canada] ; Matthew J. Lavoie [États-Unis] ; Ruth S. Slack [Canada] ; YONG RAO [Canada] ; ZHUOHUA ZHANG [États-Unis] ; BINGWEI LU [États-Unis] ; M. Emdadul Haque [Canada] ; David S. Park [Canada] | Leucine-rich repeat kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease |
| 000448 |
Oliver Cooper [États-Unis] ; Arnar Astradsson [États-Unis] ; Penny Hallett [États-Unis] ; Harold Robertson [Canada] ; Ivar Mendez [Canada] ; Ole Isacson [États-Unis] | Lack of functional relevance of isolated cell damage in transplants of Parkinson's disease patients |
| 000449 |
S. J. Palmer [Canada] ; L. Eigenraam [Canada] ; T. Hoque [Canada] ; R. G. Mccaig [Canada] ; A. Troiano [Canada] ; M. J. Mckeown [Canada] | LEVODOPA-SENSITIVE, DYNAMIC CHANGES IN EFFECTIVE CONNECTIVITY DURING SIMULTANEOUS MOVEMENTS IN PARKINSON'S DISEASE |
| 000452 |
Kaviraja Udupa [Canada] ; ZHEN NI [Canada] ; Carolyn Gunraj [Canada] ; Robert Chen [Canada] | Interactions between short latency afferent inhibition and long interval intracortical inhibition |
| 000453 |
Emily N. Mangano [Canada] ; Shawn Hayley [Canada] | Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: Neuroimmune sensitization of neurodegeneration |
| 000454 |
T. D. L. Steeves [Canada] ; J. Miyasaki [Canada] ; M. Zurowski [Canada] ; A. E. Lang [Canada] ; G. Pellecchia [Canada] ; T. Van Eimeren [Canada] ; P. Rusjan [Canada] ; S. Houle [Canada] ; A. P. Strafella [Canada] | Increased striatal dopamine release in Parkinsonian patients with pathological gambling : a [11C] raclopride PET study |
| 000455 |
Andrew H. Evans [Australie] ; Antonio P. Strafella [Canada] ; Daniel Weintraub [États-Unis] ; Mark Stacy [États-Unis] | Impulsive and Compulsive Behaviors in Parkinson's Disease |
| 000456 |
Alberto J. Espay [Canada, États-Unis] ; Dorcas E. Beaton [Canada] ; Francesca Morgante [Canada, Italie] ; Carolyn A. Gunraj [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada] | Impairments of Speed and Amplitude of Movement in Parkinson's Disease: A Pilot Study |
| 000457 |
J. Chu [Canada] ; A. Wagle-Shukla [Canada] ; C. Gunraj [Canada] ; A. E. Lang [Canada] ; R. Chen [Canada] | Impaired presynaptic inhibition in the motor cortex in Parkinson disease |
| 000458 |
Ronald B. Postuma [Canada] ; Jean-Francois Gagnon [Canada] ; Melanie Vendette [Canada] ; Jacques Y. Montplaisir [Canada] | Idiopathic REM Sleep Behavior Disorder in the Transition to Degenerative Disease |
| 000459 |
D. Litteljohn [Canada] ; E. Mangano [Canada] ; N. Shukla [Canada] ; S. Hayley [Canada] | INTERFERON-γ DEFICIENCY MODIFIES THE MOTOR AND CO-MORBID BEHAVIORAL PATHOLOGY AND NEUROCHEMICAL CHANGES PROVOKED BY THE PESTICIDE PARAQUAT |
| 000460 |
D. Mongeon [Canada] ; P. Blanchet [Canada] ; J. Messier [Canada] | IMPACT OF PARKINSON'S DISEASE AND DOPAMINERGIC MEDICATION ON PROPRIOCEPTIVE PROCESSING |
| 000461 |
Richard M. Camicioli [Canada] ; Thomas P. Bouchard [Canada] ; Martin J. Somerville [Canada] | Homocysteine Is Not Associated with Global Motor or Cognitive Measures in Nondemented Older Parkinson's Disease Patients |
| 000463 |
Christine Klein [Allemagne, Canada] ; Susanne A. Schneider [Allemagne, Royaume-Uni] ; Anthony E. Lang [Canada] | Hereditary Parkinsonism: Parkinson Disease Look-Alikes: An Algorithm for Clinicians to "PARK" Genes and Beyond |
| 000465 |
Hillel Zukor [Canada] ; WEI SONG [Canada] ; Adrienne Liberman [Canada] ; JEANNIE MUI [Canada] ; Hojatollah Vali [Canada] ; Carine Fillebeen [Canada] ; Kostas Pantopoulos [Canada] ; Ting-Di Wu [France] ; Jean-Luc Guerquin-Kern [France] ; Hyman M. Schipper [Canada] | HO-1-mediated macroautophagy : a mechanism for unregulated iron deposition in aging and degenerating neural tissues |
| 000466 |
JING JI [États-Unis] ; Mélanie Bourque [Canada] ; Thérèse Di Paolo [Canada] ; Dean E. Dluzen [États-Unis] | Genetic alteration in the dopamine transporter differentially affects male and female nigrostriatal transporter systems |
| 000467 |
Stephanie A. Cobb [États-Unis] ; Christian Wider [États-Unis] ; Owen A. Ross [États-Unis] ; Ignacio F. Mata [États-Unis] ; Charles H. Adler [États-Unis] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Ruey-Meei Wu [Taïwan] ; Robert Hauser [États-Unis] ; Keith A. Josephs [États-Unis] ; Jonathan Carr [Afrique du Sud] ; Katrina Gwinn [États-Unis] ; Michael G. Heckman [États-Unis] ; Jan O. Aasly [Norvège] ; Timothy Lynch [Irlande (pays)] ; Ryan J. Uitti [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; Gregory Kapatos [États-Unis] ; Matthew J. Farrer [États-Unis] | GCH1 in Early-Onset Parkinson's Disease |
| 000468 |
Christian Wider [États-Unis] ; Justus C. Dachsel [États-Unis] ; Alexandra I. Soto [États-Unis] ; Michael G. Heckman [États-Unis] ; Nancy N. Diehl [États-Unis] ; MEI YUE [États-Unis] ; Sarah Lincoln [États-Unis] ; Jan O. Aasly [Norvège] ; Kristoffer Haugarvoll [États-Unis, Norvège] ; John Q. Trojanowski [États-Unis] ; Spiridon Papapetropoulos [États-Unis] ; Deborah Mash [États-Unis] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; J. Mark Gibson [Irlande (pays)] ; Timothy Lynch [Irlande (pays)] ; Dennis W. Dickson [États-Unis] ; Ryan J. Uitti [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; Matthew J. Farrer [États-Unis] ; Owen A. Ross [États-Unis] | FGF20 and Parkinson's Disease : No Evidence of Association or Pathogenicity via oc-Synuclein Expression |
| 000470 |
Kenneth D. Cronin [États-Unis] ; DONGLIANG GE [États-Unis] ; Paul Manninger [Canada] ; Colton Linnertz [États-Unis] ; Anna Rossoshek [États-Unis] ; Bonnie M. Orrison [États-Unis] ; David J. Bernard [États-Unis] ; Omar M. A. Ei-Agnaf [Émirats arabes unis] ; Michael G. Schlossmacher [Canada] ; Robert L. Nussbaum [États-Unis] ; Ornit Chiba-Falek [États-Unis] | Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human α-synuclein in transgenic mouse brain |
| 000472 |
Behzad Elahi [Canada] ; Behrad Elahi [Iran] ; Robert Chen [Canada] | Effect of Transcranial Magnetic Stimulation on Parkinson Motor Function : Systematic Review of Controlled Clinical Trials |
| 000474 |
Thilo Van Eimeren [Canada] ; Oury Monchi [Canada] ; Benedicte Ballanger [Canada] ; Antonio P. Strafella [Canada] | Dysfunction of the Default Mode Network in Parkinson Disease: A Functional Magnetic Resonance Imaging Study |
| 000475 |
Robert A. Hauser [États-Unis] ; Michel Panisset [Canada] ; Giovanni Abbruzzese [Italie] ; Linda Mancione [États-Unis] ; Nalina Dronamraju [États-Unis] ; Algirdas Kakarieka [Suisse] | Double-Blind Trial of Levodopa/Carbidopa/Entacapone Versus Levodopa/Carbidopa in Early Parkinson's Disease |
| 000476 |
Jennifer R. St. Onge [Canada] ; Stan B. Floresco [Canada] | Dopaminergic Modulation of Risk-Based Decision Making |
| 000477 |
Abdoul Kane [Canada] ; William D. Hutchison [États-Unis, Canada] ; Mojgan Hodaie [États-Unis, Canada] ; Andres M. Lozano [États-Unis, Canada] ; Jonathan O. Dostrovsky [États-Unis, Canada] | Dopamine-dependent high-frequency oscillatory activity in thalamus and subthalamic nucleus of patients with Parkinson's disease |
| 000478 |
Vesna Sossi [Canada] ; Katherine Dinelle [Canada] ; Geoffrey J. Topping [Canada] ; James E. Holden [États-Unis] ; Doris Doudet [Canada] ; Michael Schulzer [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] ; Raul De La Fuente-Femandez [Canada] | Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson's : an in vivo imaging study |
| 000479 |
Atsuko Nagano-Saito [Canada] ; JIAQIANG LIU [Canada] ; Julien Doyon [Canada] ; Alain Dagher [Canada] | Dopamine modulates default mode network deactivation in elderly individuals during the Tower of London task |
| 000481 |
Claire Gibrat [Canada] ; Martine Saint-Pierre [Canada] ; Mélanie Bousquet [Canada] ; Daniel Levesque [Canada] ; Claude Rouillard [Canada] ; Francesca Cicchetti [Canada] | Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and α-synuclein inclusions |
| 000482 |
Isabelle Boileau [Canada] ; Mark Guttman [Canada] ; Pablo Rusjan [Canada] ; John R. Adams [Canada] ; Sylvain Houle [Canada] ; JUNCHAO TONG [Canada] ; Oleh Hornykiewicz [Autriche] ; Yoshiaki Furukawa [Canada] ; Alan A. Wilson [Canada] ; Shitij Kapur [Canada] ; Stephen J. Kish [Canada] | Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naïve Parkinson's disease |
| 000483 |
C. K. Young [Canada] ; S. J. Koke [Canada] ; Z. H. Kiss [Canada] ; B. H. Bland [Canada] | DEEP BRAIN STIMULATION OF THE POSTERIOR HYPOTHALAMIC NUCLEUS REVERSES AKINESIA IN BILATERALLY 6-HYDROXYDOPAMINE-LESIONED RATS |
| 000484 |
A. H. Rajput [Canada] ; A. Voll [Canada] ; M. L. Rajput [Canada] ; C. A. Robinson [Canada] ; A. Rajput [Canada] | Course in Parkinson disease subtypes: A 39-year clinicopathologic study |
| 000485 |
M. Mallar Chakravarty [Canada] ; Abbas F. Sadikot [Canada] ; Jürgen Germany [Canada] ; Pierre Hellier [France] ; Gilles Bertrand [Canada] ; D. Louis Collins [Canada] | Comparison of Piece-Wise Linear, Linear, and Nonlinear Atlas-to-Patient Warping Techniques: Analysis of the Labeling of Subcortical Nuclei for Functional Neurosurgical Applications |
| 000486 |
C. Warren Olanow [États-Unis] ; Jean-Michel Gracies [États-Unis] ; Christopher G. Goetz [États-Unis] ; A. Jon Stoessl [Canada] ; Thomas Freeman [États-Unis] ; Jeffrey H. Kordower [États-Unis] ; James Godbold [États-Unis] ; Jose A. Obeso [Espagne] | Clinical Pattern and Risk Factors for Dyskinesias Following Fetal Nigral Transplantation in Parkinson's Disease : A Double Blind Video-Based Analysis |
| 000487 |
D. F. Fotiou [Grèce] ; V. Stergiou [Grèce] ; D. Tsiptsios [Grèce] ; C. Lithari [Grèce] ; M. Nakou [Grèce] ; A. Karlovasitou [Grèce] | Cholinergic deficiency in Alzheimer's and Parkinson's disease: Evaluation with pupillometry |
| 000488 |
Benedicte Ballanger [Canada] ; Andres M. Lozano [Canada] ; Elena Moro [Canada] ; Thilo Van Eimeren [Canada] ; Clement Hamani [Canada] ; Robert Chen [Canada] ; Roberto Cilia [Canada] ; Sylvain Houle [Canada] ; YU YAN POON [Canada] ; Anthony E. Lang [Canada] ; Antonio P. Strafella [Canada] | Cerebral Blood Flow Changes Induced by Pedunculopontine Nucleus Stimulation in Patients With Advanced Parkinson's Disease: A [15O] H2O PET Study |
| 000489 |
A. W. Zuardi [Brésil] ; J. A. S. Crippa [Brésil] ; J. E. C. Hallak [Brésil] ; J. P. Pinto [Brésil] ; M. H. N. Chagas [Brésil] ; G. G. R. Rodrigues [Brésil] ; S. M. Dursun [Canada] ; V. Tumas [Brésil] | Cannabidiol for the treatment of psychosis in Parkinson's disease |
| 000490 |
M. Denheyer [Canada] ; Z. H. Kiss [Canada] ; A. M. Haffenden [Canada] | Behavioral effects of subthalamic deep brain stimulation in Parkinson's disease |
| 000491 |
Dirk W. Luchtman [Canada] ; DI SHAO [Canada] ; CAI SONG [Canada] | Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease |
| 000493 |
Moonhee Lee [Canada] ; Claudia Schwab [Canada] ; SHENG YU [Canada] ; Edith Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide |
| 000494 |
Alex Rajput [Canada] ; Carles Vilarino-Güell [États-Unis] ; Michele L. Rajput [Canada] ; Owen A. Ross [États-Unis] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Sarah J. Lincoln [États-Unis] ; Stephanie A. Cobb [États-Unis] ; Michael G. Heckman [États-Unis] ; Matthew J. Farrer [États-Unis] ; Ali Rajput [Canada] | Alpha-Synuclein Polymorphisms are Associated with Parkinson's Disease in a Saskatchewan Population |
| 000495 |
Ana Djarmati [Allemagne] ; Johann Hagenah [Allemagne] ; Kathrin Reetz [Allemagne] ; Susen Winkler [Allemagne] ; Maria Isabel Behrens [Chili] ; Heike Pawlack [Allemagne] ; Katja Lohmann [Allemagne] ; Alfredo Ramirez [Allemagne] ; Vera Tadic [Allemagne] ; Norbert Brüggemann [Allemagne] ; Daniela Berg [Allemagne] ; Hartwig R. Siebner [Allemagne] ; Anthony E. Lang [Canada] ; Peter P. Pramstaller [Italie] ; Ferdinand Binkofski [Allemagne] ; Vladimir S. Kostic [Serbie] ; Jens Volkmann [Allemagne] ; Thomas Gasser [Allemagne] ; Christine Klein [Allemagne] | ATP13A2 Variants in Early-Onset Parkinson's Disease Patients and Controls |
| 000496 |
Elena Moro [Canada] ; Niels Allert [Allemagne] ; Roberto Eleopra [Italie] ; Jean-Luc Houeto [France] ; Tra-Mi Phan [Suisse] ; Herman Stoevelaar [Belgique] | A decision tool to support appropriate referral for deep brain stimulation in Parkinson's disease |
| 000497 |
Bernard Ravina [États-Unis] ; Caroline Tanner [États-Unis] ; Diane Dieuliis [États-Unis] ; Shirley Eberly [États-Unis] ; Emily Flagg [États-Unis] ; Wendy R. Galpern [États-Unis] ; Stanley Fahn [États-Unis] ; Christopher G. Goetz [États-Unis] ; Stephen Grate [États-Unis] ; Roger Kurlan [États-Unis] ; Anthony E. Lang [Canada] ; Kenneth Marek [États-Unis] ; Karl Kieburtz [États-Unis] ; David Oakes [États-Unis] ; Robin Elliott [États-Unis] ; Ira Shoulson [États-Unis] | A Longitudinal Program for Biomarker Development in Parkinson's Disease: A Feasibility Study |
| 000498 |
C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Robert Hauser [États-Unis] ; Paul D. Feigin [Israël] ; Joseph Jankovic [États-Unis] ; Anthony Lang [Canada] ; William Langston [États-Unis] ; Eldad Melamed [Israël] ; Werner Poewe [Autriche] ; Fabrizio Stocchi [Italie] ; Eduardo Tolosa [Espagne] | A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease |
| 000499 |
Connie Marras [Canada] ; Anthony E. Lang [Canada] ; Shirley W. Eberly [États-Unis] ; David Oakes [États-Unis] ; Stanley Fahn [États-Unis] ; Steven R. Schwid [États-Unis] ; Christopher Hyson [Canada] ; Ira Shoulson [États-Unis] | A Comparison of Treatment Thresholds in Two Large Parkinson's Disease Clinical Trial Cohorts |
| 000500 |
Laurent Gregoire [Canada] ; Arash Rassoulpour [États-Unis] ; Paolo Guidetti [États-Unis] ; Pershia Samadi [Canada] ; Paul J. Bedard [Canada] ; Emanuela Izzo [Italie] ; Robert Schwarcz [États-Unis] ; Therese Di Paolo [Canada] | Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys |
| 000502 |
Antonio P. Strafella [Canada] ; Andres M. Lozano [Canada] ; Benedicte Ballanger [Canada] ; Yu-Yan Poon [Canada] ; Anthony E. Lang [Canada] ; Elena Moro [Canada] | rCBF Changes Associated with PPN Stimulation in a Patient with Parkinson's disease : A PET Study |
| 000504 |
Chinar Dara [Canada] ; Laura Monetta [Canada] ; Marc D. Pell [Canada] | Vocal emotion processing in Parkinson's disease : Reduced sensitivity to negative emotions |
| 000505 |
Patrick Fitzgerald [Irlande (pays)] ; Arkady Mandel [Canada] ; Anthony E. Bolton [Irlande (pays)] ; Aideen M. Sullivan [Irlande (pays)] ; Yvonne Nolan [Irlande (pays)] | Treatment with phosphotidylglycerol-based nanoparticles prevents motor deficits induced by proteasome inhibition : Implications for Parkinson's disease |
| 000506 |
Michal Harciarek [Canada, Pologne] ; Andrew Kertesz [Canada] | The Prevalence of Misidentification Syndromes in Neurodegenerative Diseases |
| 000507 |
Naomi P. Visanji [Canada] ; Rob M. A. De Bie [Canada] ; Tom H. Johnston [Canada] ; Andrew C. Mccreary [Pays-Bas] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada] | The Nociceptin/Orphanin FQ (NOP) Receptor Antagonist J-113397 Enhances the Effects of Levodopa in the MPTP-Lesioned Nonhuman Primate Model of Parkinson's Disease |
| 000508 |
Renato P. Munhoz [Brésil] ; Yosuke Wakutani [Canada] ; Connie Marras [Canada] ; Helio A. Teive [Brésil] ; Salmo Raskin [Brésil] ; Lineu C. Werneck [Brésil] ; Danielle Moreno [Canada] ; Christine Sato [Canada] ; Anthony E. Lang [Canada] ; Ekaterina Rogaeva [Canada] | The G2019S LRRK2 Mutation in Brazilian Patients with Parkinson's Disease : Phenotype in Monozygotic Twins |
| 000510 |
Dan A. Mendonca [Canada] ; Mandar S. Jog [Canada] | Tasks of Attention Augment Rigidity in Mild Parkinson Disease |
| 000512 |
Margaret K. Y. Mak [Hong Kong] ; Aftab Patla [Canada] ; Christina Hui-Chan [Hong Kong] | Sudden turn during walking is impaired in people with Parkinson's disease |
| 000513 |
Jasper E. Visser [Pays-Bas, Suisse] ; John H. J. Allum [Suisse] ; Mark G. Carpenter [Suisse, Canada] ; Rianne A. Esselink [Pays-Bas] ; Johannes D. Speelman [Pays-Bas] ; George F. Borm [Pays-Bas] ; Bastiaan R. Bloem [Pays-Bas] | Subthalamic nucleus stimulation and levodopa-resistant postural instability in Parkinson's disease |
| 000514 |
Anthony P. Nicholas [États-Unis] ; Farah D. Lubin [États-Unis] ; Penelope J. Hallett [États-Unis] ; Padmapriya Vattem [États-Unis] ; Paula Ravenscroft [Royaume-Uni] ; Erwan Bezard [France] ; SHAOBO ZHOU [Royaume-Uni] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada] ; J. David Sweatt [États-Unis] ; David G. Standaert [États-Unis] | Striatal histone modifications in models of levodopa-induced dyskinesia |
| 000515 |
Alison Fenney [Canada] ; Mandar S. Jog [Canada] ; Christian Duval [Canada] | Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea |
| 000516 |
Mya Schiess [États-Unis] ; Irene Oh ; Michael A. Schwarzschild [États-Unis] ; Steven R. Schwid [États-Unis] ; Kenneth Marek [États-Unis] ; Arthur Watts [États-Unis] ; Anthony E. Lang [Canada] ; David Oakes [États-Unis] ; Ira Shoulson [États-Unis] ; Alberto Ascherio [États-Unis] | Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease. Commentary |
| 000517 |
F. Paquet [Canada] ; M. A. Bedard [Canada] ; M. Levesque [Canada] ; P. L. Tremblay [Canada] ; M. Lemay [Canada] ; P. J. Blanchet [Canada] ; P. Scherzer [Canada] ; S. Chouinard [Canada] ; J. Filion [Canada] | Sensorimotor adaptation in Parkinson's disease : evidence for a dopamine dependent remapping disturbance |
| 000518 |
Anita L. Destefano [États-Unis] ; Jeanne Latourelle [États-Unis] ; Mark F. Lew [États-Unis] ; Oksana Suchowersky [Canada] ; Christine Klein [Allemagne] ; Lawrence I. Golbe [États-Unis] ; Margery H. Mark [États-Unis] ; John H. Growdon [États-Unis] ; G. Fredrick Wooten [États-Unis] ; Ray Watts [États-Unis] ; Mark Guttman [Canada] ; Brad A. Racette [États-Unis] ; Joel S. Perlmutter [États-Unis] ; Lynn Marlor [États-Unis] ; Holly A. Shill [États-Unis] ; Carlos Singer [États-Unis] ; Stefano Goldwurm [Italie] ; Gianni Pezzoli [Italie] ; Marie H. Saint-Hilaire [États-Unis] ; Audrey E. Hendricks [États-Unis] ; Adam Gower ; Sally Williamson [États-Unis] ; Michael W. Nagle [États-Unis] ; Jemma B. Wilk [États-Unis] ; Tiffany Massood [États-Unis] ; Karen W. Huskey [États-Unis] ; Kenneth B. Baker ; Ilia Itin ; Irene Litvan ; Garth Nicholson ; Alastair Corbett ; Martha Nance ; Edward Drasby ; Stuart Isaacson ; David J. Burn ; Patrick F. Chinnery ; Peter P. Pramstaller ; Jomana Al-Hinti ; Anette T. Moller ; Karen Ostergaard ; Scott J. Sherman ; Richard Roxburgh ; Barry Snow ; John T. Slevin ; Franca Cambi ; James F. Gusella ; Richard H. Myers [États-Unis] | Replication of association between ELAVL4 and Parkinson disease : the GenePD study |
| 000519 |
R. B. Posturna [Canada] ; J. F. Gagnon [Canada] ; M. Vendette [Canada] ; K. Charland [Canada] ; J. Montplaisir [Canada] | REM sleep behaviour disorder in Parkinson's disease is associated with specific motor features |
| 000521 |
Stephen J. Kish [Canada] ; JUNCHAO TONG [Canada] ; Oleh Hornykiewicz [Autriche] ; Ali Rajput [Canada] ; Li-Jan Chang [Canada] ; Mark Guttman [Canada] ; Yoshiaki Furukawa [Canada] | Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease |
| 000522 |
Connie Marras [Canada] ; Michael P. Mcdermott [États-Unis] ; Paula A. Rochon [Canada] ; Caroline M. Tanner [États-Unis] ; Gary Naglie [Canada] ; Anthony E. Lang [Canada] | Predictors of Deterioration in Health-Related Quality of Life in Parkinson's Disease : Results from the DATATOP Trial |
| 000523 |
Anne Beuter [France] ; Roberto Hernandez [Canada] ; Robert Rigal [Canada] ; Julien Modolo [France] ; Pierre J. Blanchet [Canada] | Postural Sway and Effect of Levodopa in Early Parkinson's Disease |
| 000525 |
Moran Weinberger [Canada] ; Clement Hamani [Canada] ; William D. Hutchison [Canada] ; Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Jonathan O. Dostrovsky [Canada] | Pedunculopontine nucleus microelectrode recordings in movement disorder patients |
| 000527 |
Cory Toth [Canada] ; Martin Sutton Brown [Canada] ; Sarah Furtado [Canada] ; Oksana Suchowersky [Canada] ; Douglas Zochodne [Canada] | Neuropathy as a Potential Complication of Levodopa Use in Parkinson's Disease |
| 000528 |
J.-F. Gagnon [Canada] ; D. Petit [Canada] ; V. Latreille [Canada] ; J. Montplaisir [Canada] | Neurobiology of Sleep Disturbances in Neurodegenerative Disorders |
| 000529 |
M. H. Beauchamp [Canada] ; A. Dagher [Canada] ; M. Panisset [Canada] ; J. Doyon [Canada] | Neural substrates of cognitive skill learning in Parkinson's disease |
| 000530 |
Y.-Y. Lai [États-Unis] ; K.-C. Hsieh [États-Unis] ; D. Nguyen [États-Unis] ; J. Peever [Canada] ; J. M. Siegel [États-Unis] | NEUROTOXIC LESIONS AT THE VENTRAL MESOPONTINE JUNCTION CHANGE SLEEP TIME AND MUSCLE ACTIVITY DURING SLEEP : AN ANIMAL MODEL OF MOTOR DISORDERS IN SLEEP |
| 000532 |
Christopher G. Goetz [États-Unis] ; Barbara C. Tilley [États-Unis] ; Stephanie R. Shaftman [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Stanley Fahn [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Wemer Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Matthew B. Stem [États-Unis] ; Richard Dodel [Allemagne] ; Bruno Dubois [France] ; Robert Holloway [États-Unis] ; Joseph Jankovic [États-Unis] ; Jaime Kulisevsky [Espagne] ; Anthony E. Lane [Canada] ; Andrew Lees [Royaume-Uni] ; Sue Leurgans [États-Unis] ; Peter A. Le Witt [États-Unis] ; David Nyenhuis [États-Unis] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Anette Schrag [Royaume-Uni] ; Jeanne A. Teresi [États-Unis] ; Jacobus J. Van Hilten [Pays-Bas] ; Nancy Lapelle [États-Unis] | Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) : Scale Presentation and Clinimetric Testing Results |
| 000533 |
W. R. Wayne Martin [Canada] ; Marguerite Wieler [Canada] ; Myrlene Gee [Canada] | Midbrain iron content in early Parkinson disease : A potential biomarker of disease status |
| 000534 |
Ronald B. Postuma [Canada] ; Jean-Francois Gagnon [Canada] ; Melanie Vendette [Canada] ; Katia Charland [Canada] ; Jacques Montplaisir [Canada] | Manifestations of Parkinson Disease Differ in Association with REM Sleep Behavior Disorder |
| 000535 |
Susan H. Fox [Canada] ; Anthony E. Lang [Canada] | Levodopa-Related Motor Complications-Phenomenology |
| 000537 |
Jorge Guridi [Espagne] ; Jose A. Obeso [Espagne] ; Maria C. Rodriguez-Oroz [Espagne] ; Andres A. Lozano [Canada] ; Miguel Manrique [Espagne] ; Philip A. Starr ; Julie G. Pilitsis ; Roy A. E. Bakay ; Marwan I. Hariz ; Ventura Arjona ; Jose G. Martin-Rodriguez | L-DOPA-INDUCED DYSKINESIA AND STEREOTACTIC SURGERY FOR PARKINSON'S DISEASE. Commentaries |
| 000538 |
Connie Marras [Canada] ; Anthony Lang [Canada] | Invited Article: Changing concepts in Parkinson disease : Moving beyond the Decade of the Brain |
| 000539 |
R. Nandhagopal [Canada] ; Martin J. Mckeown [Canada] ; A. Jon Stoessl [Canada] | Invited Article : Functional imaging in Parkinson disease |
| 000540 |
W. R. Wayne Martin [Canada] ; Marguerite Wieler [Canada] ; Myrlene Gee [Canada] ; Christopher C. Hanstock [Canada] ; Richard M. Camicioli [Canada] | Intact Presupplementary Motor Area Function in Early, Untreated Parkinson's Disease |
| 000541 |
Christopher F. Mcnicoll [États-Unis] ; Jeanne C. Latourelle [États-Unis] ; Marcy E. Macdonald [États-Unis] ; Mark F. Lew [États-Unis] ; Oksana Suchowersky [Canada] ; Christine Klein [Allemagne] ; Lawrence I. Golbe [États-Unis] ; Margery H. Mark [États-Unis] ; John H. Growdon [États-Unis] ; G. Frederick Wooten [États-Unis] ; Ray L. Watts [États-Unis] ; Mark Guttman [Canada] ; Brad A. Racette [États-Unis] ; Joel S. Perlmutter [États-Unis] ; Anwar Ahmed [États-Unis] ; Holly A. Shill [États-Unis] ; Carlos Singer [États-Unis] ; Marie H. Saint-Hilaire [États-Unis] ; Tiffany Massood [États-Unis] ; Karen W. Huskey [États-Unis] ; Anita L. Destefano [États-Unis] ; Tammy Gillis [États-Unis] ; Jayalakshmi Mysore [États-Unis] ; Stefano Goldwurm [Italie] ; Gianni Pezzoli [Italie] ; Kenneth B. Baker [États-Unis] ; Ilia Itin [États-Unis] ; Irene Litvan [États-Unis] ; Garth Nicholson [Australie] ; Alastair Corbett [Australie] ; Martha Nance [États-Unis] ; Edward Drasby [États-Unis] ; Stuart Isaacson [États-Unis] ; David J. Burn [Royaume-Uni] ; Patrick F. Chinnery ; Peter P. Pramstaller ; Jomana Al-Hinti ; Anette T. Moller ; Karen Ostergaard ; Scott J. Sherman ; Richard Roxburgh ; Barry Snow ; John T. Slevin ; Franca Cambi ; James F. Gusella [États-Unis] ; Richard H. Myers [États-Unis] | Huntington CAG Repeat Size Does Not Modify Onset Age in Familial Parkinson's Disease : The GenePD Study |
| 000542 |
Jesse Jackson [Canada] ; Calvin K. Young [Canada] ; BIN HU [Canada] ; Brian H. Bland [Canada] | High frequency stimulation of the posterior hypothalamic nucleus restores movement and reinstates hippocampal-striatal theta coherence following haloperidol-induced catalepsy |
| 000543 |
Mary De Vera [Canada] ; M. Mushfiqur Rahman [Canada] ; James Rankin [Canada] ; Jacek Kopec [Canada] ; XIANG GAO [États-Unis] ; Hyon Choi [Canada] | Gout and the Risk of Parkinson's Disease : A Cohort Study |
| 000545 |
Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada] | Glial Reactions in Parkinson's Disease |
| 000546 |
Frank J. S. Lee [Canada] ; FANG LIU [Canada] | Genetic factors involved in the pathogenesis of Parkinson's disease |
| 000550 |
Isabelle Boileau [Canada] ; Jerry J. Warsh [Canada] ; Mark Guttman [Canada] ; Jean A. Saint-Cyr [Canada] ; Tina Mccluskey [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Alan A. Wilson [Canada] ; Jeffrey H. Meyer [Canada] ; Stephen J. Kish [Canada] | Elevated Serotonin Transporter Binding in Depressed Patients with Parkinson's Disease : A Preliminary PET Study with [11C]DASB |
| 000551 |
Richard M. Camicioli [Canada] ; Marguerite Wieler [Canada] ; Cindy M. De Frias [Canada] ; W. R. Wayne Martin [Canada] | Early, untreated Parkinson's disease patients show reaction time variability |
| 000552 |
J. E. Visser [Pays-Bas, Suisse] ; J. H. J. Allum [Suisse] ; M. G. Carpenter [Suisse, Canada] ; R. A. J. Esselink [Pays-Bas] ; P. Limousin-Dowsey [Royaume-Uni] ; F. Honegger [Suisse] ; G. F. Borm [Pays-Bas] ; B. R. Bloem [Pays-Bas] | EFFECT OF SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION ON AXIAL MOTOR CONTROL AND PROTECTIVE ARM RESPONSES IN PARKINSON'S DISEASE |
| 000553 |
I. Rektorova [République tchèque] ; S. Sedlackova [République tchèque] ; S. Telecka [République tchèque] ; A. Hlubocky [République tchèque] ; I. Rektor [République tchèque] | Dorsolateral Prefrontal Cortex : A Possible Target for Modulating Dyskinesias in Parkinson's Disease by Repetitive Transcranial Magnetic Stimulation |
| 000554 |
Shen-Yang Lim [Australie] ; Michael J. Farrell [Australie] ; Stephen J. Gibson [Australie] ; Robert D. Helme [Australie] ; Anthony E. Lang [Canada] ; Andrew H. Evans [Australie] | Do Dyskinesia and Pain Share Common Pathophysiological Mechanisms in Parkinson's Disease? |
| 000556 |
W. R. Wayne Martin [Canada] ; Marguerite Wieler [Canada] ; A. Jon Stoessl [Canada] ; Michael Schulzer [Canada] | Dihydrotetrabenazine Positron Emission Tomography Imaging in Early, Untreated Parkinson's Disease |
| 000557 |
XIANG GAO [États-Unis] ; HONGLEI CHEN [États-Unis] ; Hyon K. Choi [États-Unis, Canada] ; Gary Curhan [États-Unis] ; Michael A. Schwarzschild [États-Unis] ; Alberto Ascherio [États-Unis] | Diet, Urate, and Parkinson's Disease Risk in Men |
| 000558 |
Werner Poewe [Autriche] ; S. Gauthier [Canada] ; D. Aarsland [Norvège] ; J. B. Leverenz [États-Unis] ; P. Barone [Italie] ; D. Weintraub [États-Unis] ; E. Tolosa [Espagne] ; B. Dubois [France] | Diagnosis and management of Parkinson's disease dementia |
| 000559 |
Teneille E. Gofton [Canada] ; Mandar Jog [Canada] | Diagnosing Parkinson's Disease : The Patient Perspective |
| 000560 |
Andres M. Lozano [Canada] ; Brian J. Snyder [Canada] | Deep brain stimulation for parkinsonian gait disorders |
| 000561 |
Francois Tremblay [Canada] ; Guillaume Leonard [Canada] ; Louis Tremblay [Canada] | Corticomotor facilitation associated with observation and imagery of hand actions is impaired in Parkinson's disease |
| 000562 |
Alison R. Oates [Canada] ; Jim S. Frank [Canada] ; Aftab E. Patla [Canada] ; Karen Vanooteghem [Canada] ; Fay B. Horak [États-Unis] | Control of Dynamic Stability During Gait Termination on a Slippery Surface in Parkinson's Disease |
| 000563 |
Yuri M. Andrade-Souza [Canada] ; Jason M. Schwalb [Canada] ; Clement Hamani [Canada] ; Hazem Eltahawy [Canada] ; Tasnuva Hoque [Canada] ; Jean Saint-Cyr [Canada] ; Andres M. Lozano [Canada] ; Roy A. E. Bakay ; Ali R. Rezai ; Philip A. Starr | COMPARISON OF THREE METHODS OF TARGETING THE SUBTHALAMIC NUCLEUS FOR CHRONIC STIMULATION IN PARKINSON'S DISEASE |
| 000564 |
Alison Fenney [Canada] ; Mandar S. Jog [Canada] ; Christian Duval [Canada] | Bradykinesia is not a "systematic" feature of adult-onset Huntington's disease; implications for basal ganglia pathophysiology |
| 000566 |
Jon B. Doan [Canada] ; Kyle G. Melvin [Canada] ; Ian Q. Whishaw [Canada] ; Oksana Suchowersky [Canada] | Bilateral impairments of skilled reach-to-eat in early Parkinson's disease patients presenting with unilateral or asymmetrical symptoms |
| 000567 |
Clement Hamani [Canada] ; Erich Richter [Canada] ; Jason M. Schwalb [Canada] ; Andres M. Lozano [Canada] ; Roy A. E. Bakay ; Scott C. Kutz ; Alim-Louis Benabid ; Philip A. Starr ; Brian H. Kopell ; Ali R. Rezai ; Giovanni Broggi ; Angelo Franzini | BILATERAL SUBTHALAMIC NUCLEUS STIMULATION FOR PARKINSON'S DISEASE : A SYSTEMATIC REVIEW OF THE CLINICAL LITERATURE |
| 000569 |
Peter A. Lewitt [États-Unis] ; M. Guttman [Canada] ; James W. Tetrud [États-Unis] ; Paul J. Tuite [États-Unis] ; Akihisa Mori [Japon] ; Philip Chaikin [États-Unis] ; Neil M. Sussman [États-Unis] | Adenosine A2A Receptor Antagonist Istradefylline (KW-6002) Reduces "Off' Time in Parkinson's Disease : A Double-Blind, Randomized, Multicenter Clinical Trial (6002-US-005) |
| 000570 |
Maria Fraraccio [Canada] ; Alain Ptito [Canada] ; Abbas Sadikot [Canada] ; Michel Panisset [Canada] ; Alain Dagher [Canada] | Absence of cognitive deficits following deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease |
| 000571 |
K. Mukhida [Canada] ; M. Hong [Canada] ; G. B. Miles [Canada] ; T. Phillips [Canada] ; B. A. Baghbaderani [Canada] ; M. Mcleod [Canada] ; N. Kobayashi [Canada] ; A. Sen [Canada] ; L. A. Behie [Canada] ; R. M. Brownstone [Canada] ; I. Mendez [Canada] | A multitarget basal ganglia dopaminergic and GABAergic transplantation strategy enhances behavioural recovery in parkinsonian rats |
| 000572 |
Valerie Voon [États-Unis, Canada] ; Paul Krack [France] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; Kathy Dujardin [France] ; Michael Schüpbach [France] ; James D'Ambrosia [États-Unis] ; Stephane Thobois [France] ; Filippo Tamma [Italie] ; Jan Herzog [Allemagne] ; Johannes D. Speelman [Pays-Bas] ; Johan Samanta [États-Unis] ; Cynthia Kubu [États-Unis] ; Helene Rossignol [France] ; Yu-Yan Poon [Canada] ; Jean A. Saint-Cyr [Canada] ; Claire Ardouin [France] ; Elena Moro [Canada] | A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease |
| 000573 |
C. Warren Olanow [États-Unis] ; Robert A. Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Wemer Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France] | A Randomized, Double-Blind, Placebo-Controlled, Delayed Start Study to Assess Rasagiline as a Disease Modifying Therapy in Parkinson's Disease (The ADAGIO Study) : Rationale, Design, and Baseline Characteristics |
| 000574 |
Cindy Zadikoff [États-Unis, Canada] ; Susan H. Fox [Canada] ; David F. Tang-Wai [Canada] ; Teri Thomsen [Canada] ; Rob M. A. De Bie [Canada, Pays-Bas] ; Pettarusup Wadia [Canada] ; Janis Miyasaki [Canada] ; Sarah Duff-Canning [Canada] ; Anthony E. Lang [Canada] ; Connie Marras [Canada] | A Comparison of the Mini Mental State Exam to the Montreal Cognitive Assessment in Identifying Cognitive Deficits in Parkinson's Disease |
| 000575 |
M. Stacy [États-Unis] ; D. Silver [États-Unis] ; T. Mendis [Canada] ; J. Sutton [États-Unis] ; A. Mori [États-Unis] ; P. Chaikin [États-Unis] ; N. M. Sussman [États-Unis] | A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease |
| 000590 |
Matthew J. Lavoie [États-Unis] ; Giuseppe P. Cortese [États-Unis] ; Beth L. Ostaszewski [États-Unis] ; Michael G. Schlossmacher [Canada] | The effects of oxidative stress on parkin and other E3 ligases |
| 000592 |
Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada] | Ten-Year Follow-Up of Parkinson's Disease Patients Randomized to Initial Therapy with Ropinirole or Levodopa |
| 000598 |
Antonio P. Strafella [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] ; JI HYUN KO [Canada] ; Yu-Yan Poon [Canada] ; Elena Moro [Canada] | Subdural Motor Cortex Stimulation in Parkinson's Disease Does Not Modify Movement-Related rCBF Pattern |
| 000610 |
M. Vendette [Canada] ; J.-F. Gagnon [Canada] ; A. Decary [Canada] ; J. Massicotte-Marquez [Canada] ; R. B. Postuma [Canada] ; J. Doyon [Canada] ; M. Panisset [Canada] ; J. Montplaisir [Canada] | REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia |
| 000620 |
Christine Klein [Allemagne] ; Michael G. Schlossmacher [Canada] | Parkinson disease, 10 years after its genetic revolution : Multiple clues to a complex disorder |
| 000624 |
XINGSHUN XU [États-Unis] ; Chu C. Chua [États-Unis] ; JIMING KONG [Canada] ; Richard M. Kostrzewa [États-Unis] ; Udayasankar Kumaraguru [États-Unis] ; Ronald C. Hamdy [États-Unis] ; Balvin H. L. Chua [États-Unis] | Necrostatin-1 protects against glutamate-induced glutathione depletion and caspase-independent cell death in HT-22 cells |
| 000628 |
Dan A. Mendonca [Canada] ; Krishe Menezes [Canada] ; Mandar S. Jog [Canada] | Methylphenidate Improves Fatigue Scores in Parkinson Disease : A Randomized Controlled Trial |
| 000640 |
Teri R. Thomsen [Canada] ; Wendy R. Galpem [Canada] ; Abena Asante [Canada] ; Tamara Arenovich [Canada] ; Susan H. Fox [Canada] | Ipratropium Bromide Spray as Treatment for Sialorrhea in Parkinson's Disease |
| 000649 |
Irena Rektorova [République tchèque] ; Jennifer Barrett [Canada] ; Michal Mikl [République tchèque] ; Ivan Rektor [République tchèque] ; Tomas Paus [Canada, Royaume-Uni] | Functional Abnormalities in the Primary Orofacial Sensorimotor Cortex During Speech in Parkinson's Disease |
| 000658 |
Vesna Sossi [Canada] ; Raul De La Fuente-Fernandez [Espagne] ; Michael Schulzer [Canada] ; Andre R. Troiano [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | Dopamine Transporter Relation to Dopamine Turnover in Parkinson's Disease : A Positron Emission Tomography Study |
| 000665 |
R. M. A. De Bie [Canada, Pays-Bas] ; J. Miyasaki [Canada] ; A. E. Lang [Canada] ; S. H. Fox [Canada] | Clinical practice regarding dopamine-agonist use and driving in Parkinson's disease |
| 000677 |
Ruth M. Pickering [Royaume-Uni] ; Yvette A. M. Grimbergen [Pays-Bas] ; Una Rigney [Royaume-Uni] ; Ann Ashbum [Royaume-Uni] ; Gordon Mazibrada [Royaume-Uni] ; Brian Wood [Royaume-Uni] ; Peggy Gray [Canada] ; Graham Kerr [Australie] ; Bastiaan R. Bloem [Pays-Bas] | A meta-analysis of six prospective studies of falling in parkinson's disease |
| 000715 |
Craig J. Whittington [Royaume-Uni] ; John Podd [Nouvelle-Zélande] ; Steve Stewart-Williams [Canada] | Memory Deficits in Parkinson's Disease |
| 000B41 |
S. Briere [Canada] ; S. Lupien [Canada] ; PH.D. [Canada] | Les trous vs les troubles de la mémoire au cours du vieillissement |
| 000E46 |
H. Shinotoh [Canada] ; D. B. Calne | The use of PET in Parkinson's disease |
| 000E47 |
A. E. Taylor [Canada] ; J. A. Saint-Cyr | The neuropsychology of Parkinson's disease |
